header logo image


Page 33«..1020..32333435..»

Archive for April, 2020

‘The Incredible Dr. Pol’: Does Dr. Emily Have Children? – Showbiz Cheat Sheet

Monday, April 6th, 2020

Dr. Emily Thomas may be gone from The Incredible Dr. Pol, but shes not forgotten.

The hardworking veterinarian showed what she was made of on the reality show, putting in long hours even while far along in one of her pregnancies.

If youre wondering how many kids the Georgia native has, heres what we know.

It was hard to see Dr. Emily leave the Nat Geo Wild program. She had been a fan favorite since 2015, repositioning cows stomachs, palpating them, removing grubs from nasty infections it was all in a days work for Dr. Emily.

After she left The Incredible Dr. Pol, she was replaced by two new veterinarians, Dr. Ray Harp and Dr. Lisa Jones.

A big fan of Dr. Pols, Dr. Harp as a young man watched the reality show and was inspired to become an animal doctor seeing the tireless Dr. Pol working his rounds on various farms and at his practice.

In 2010, the 37-year-old Dr. Harp was managing a day care for dogs in Philadelphia and made the decision to return to school to become a vet technician.

It was while he was working at an animal clinic in Kansas City that he began to get the itch to become a veterinarian and gave serious thought to medical school. Encouraged by his wife, he enrolled at Kansas City University and earned his doctor of veterinary medicine degree in 2019.

He and his family ended up in Michigan, although he admits hes more of a fan of sunnier climates.

Its really beautiful, he said of Michigan. Im just worried that its going to be really snowy soon.

Dr. Emily, while she was working at Dr. Pols clinic, had her husband, Tony, working alongside her in the clinic, helping out all the veterinarians, guests, and their clients.

Currently, at the practice Dr. Emily is now working with in Virginia, her husband is working with her there as well.

Tony, writing on Dr. Emilys personal blog, said of their move, . . . when it was time to leave Michigan, we had an idea of what we wanted.

Virginia became an obvious place for us. Within Virginia, the Shenandoah Valley was appealing. The Shenandoah National Park is basically in our front yard, and there is a nice river for canoeing and kayaking.

Dr. Emily and Tony have three children: India born in 2013, Oscar born in 2015, and Calvin born in 2018.

Based on her blog, its safe to say that part of the reason so many viewers were drawn to her was for her sometimes shocking honesty. But its nothing any other mother hasnt thought at least once.

She said recently on Twitter, ALL night I was unable to sleep despite meds just imagining all of my children dying from the #Covid_19. Then, groggy early morning, I hear that all three kids are downstairs. My very first thought Ugh! I guess I better get up and go take care of those monsters.

Read more: The Incredible Dr. Pol: The Real Reason Dr. Emily Left

See the original post here:
'The Incredible Dr. Pol': Does Dr. Emily Have Children? - Showbiz Cheat Sheet

Read More...

Determining How Many Veterinarians are in the Workforce is Trickier Than You Think – PR Web

Monday, April 6th, 2020

AMES, Iowa (PRWEB) April 06, 2020

Food animal veterinarians (FAVs) are vital for the health and well-being of our nations food supply, but the profession faces challenges that are not well understood, which ultimately impacts the workforces ability to recruit and retain professionals.

FAVs are key to providing the world with a safe and secure food supply, says Dr. Christine Navarre, DVM, MS, DACVIM, of Louisiana State University. They work directly with producers to ensure the health and welfare of food producing animals as well as working in food safety and other public health areas.

Navarre recently chaired a task force addressing the issue in a new paper published by the Council for Agricultural Science and Technology (CAST). She, along with other veterinary scientists and experts, focused on two themes affecting the profession: economic and social factors.

The authors describe economic challenges as changes in the agricultural industry that affect supply and demand. The latter are often informed by available databases, for example, the American Veterinary Medical Associations membership database, which represents 82 percent of U.S. veterinarians. However, it is difficult to determine how many individuals in the database work with food-producing animals due to missing or outdated self-reported information.

Other inconsistencies also cause issues in workforce studies that are often used to inform the amount of FAV professionals in the workforce and how many are needed. A lack of detailed employment data, differences in methodology and an ever-changing animal agricultural landscape make predicting how many FAVs are needed difficult," Navarre says.

Social factors also influence students and professional veterinarians choices for where and what they practice. Among the top social challenges include the students income-to-debt ratio, which is considerably high for FAVs. Many veterinarians also cite the lack of support in rural agricultural communities among the barriers that curb them from this type of work. For example, veterinarians with spouses tend to search for communities that are capable of providing a career for their significant other.

While there are challenges to building a strong FAV workforce, the CAST papers authors outline strategies that may increase recruitment and retention for the profession.

Despite the difficulties, FAVs and the producers they serve are innovative and adaptable, and will find ways to keep providing for the health and welfare of food animals and producing safe and affordable food, Navarre says.

The paper, Impact of Recruitment and Retention of Food Animal Veterinarians on the U.S. Food Supply, is available to download for free on the CAST website. A free webinar will take place at noon CST on April 7. More information about the webinar can be found here: https://conta.cc/3bljbxl.

Task Force Authors:

About CAST The Council for Agricultural Science and Technology is an international consortium of scientific and professional societies, companies, and nonprofit organizations. Through its network of experts, CAST assembles, interprets, and communicates credible, balanced, science-based information to policymakers, the media, the private sector, and the public.http://www.cast-science.org

Share article on social media or email:

Go here to read the rest:
Determining How Many Veterinarians are in the Workforce is Trickier Than You Think - PR Web

Read More...

New therapy could combat persistent joint infections in horses – Feedstuffs

Monday, April 6th, 2020

A new therapy could combat persistent joint infections in horses, potentially saving them from years of pain, based on Morris Animal Foundation-funded research at North Carolina State University.

The North Carolina State researchers developed a platelet-rich plasma (PRP) lysate that, when teamed with antibiotics, can eradicate bacterial biofilms common in joint infections, the Morris Animal Foundation said in an announcement. The therapy could also be applied to other species, including humans and dogs.

The team published their findings in the Journal of Orthopaedic Research.

"This could really provide a more effective way of clearing a joint infection quickly so that the horse does not suffer long-term consequences of joint damage," said Dr. Lauren Schnabel, associate professor of equine orthopedic surgery at North Carolina State University, a primary investigator of the study. "For any horse's well-being, it's important to make them as comfortable as possible, as quickly as possible to avoid laminitis and other complications."

Horses are more prone to joint infections than other animals due to their predominantly outdoor, active lifestyles coupled with a lack of tissue protection over the joints of their lower limbs, the announcement explained. Any wound near a joint, regardless of its size, requires immediate veterinary attention. Left untreated, they can be life-threatening.

Current joint infection treatment usually involves surgical flushing of the joint and giving antibiotics. Despite aggressive care, about 6-10% of horses die as a result of the infection or associated complications. For horses that survive, more than 50% will suffer from chronic arthritis for the rest of their lives, the foundation said.

A common complication that impedes successful treatment is the tendency for some bacteria to form biofilms in the joint. A biofilm is a sticky, slimy shield that forms around bacteria in synovial fluid. They become so large that immune cells can't attack them properly. Biofilms also render the bacteria metabolically inactive, which makes them more resistant to antibiotics.

To create their PRP lysate, the research team took blood from the small herd of horses at the North Carolina State College of Veterinary Medicine and isolated the platelets, which are known to aid in healing. Then, the researchers packed 50 times the number of platelets that would be found in an equal amount of blood into their product. For comparison, typical PRP, for orthopedic and sports medicine purposes, is created by concentrating platelets usually up to three times what is found in a comparable amount of blood, the announcement said.

The team felt that this super-concentrated product would be better at stopping infections than conventional PRP.

The team lysed the platelets to release antimicrobial peptides -- proteins that attack bacteria. The researchers separated out the antimicrobial peptides, and then, after testing those against common bacteria, all the horses' peptides were pooled together for one lysate product. The team collected synovial fluid from the horses' knees with harmless taps. The fluid was seeded with bacteria in the laboratory and allowed to grow biofilms. Finally, researchers tested three methods to attack the biofilms: antibiotics alone, lysate alone and a combination of antibiotics and lysate.

According to the Morris Animal Foundation, the researchers found that antibiotics alone were completely ineffective, and the lysate alone significantly decreased the bacterial load. However, the antibiotic and lysate combination completely eradicated the biofilms and bacteria.

Schnabel said her team has used this experimental therapy on horses with great results. Because the process to create the lysate is both complicated and expensive, her team is trying to find a way to produce it more efficiently. They also are trying to identify the exact peptides responsible for the antibacterial properties, so they can be synthesized and production scaled up to reach the greatest number of horses, the foundation said.

"This is really a critical piece of evidence to show this is a therapy with enormous potential to make traditional antimicrobials more effective," said Dr. Janet Patterson-Kane, Morris Animal Foundation chief scientific officer. "Clearing bacteria more quickly and effectively from infected joints is a much-needed piece of the solution for this complex disease."

If successful, this approach also has translational potential to help other species, including people. For example, biofilm formation and infection are a significant problem for people with metal implants, such as those used in joint replacement surgeries. Dr. Jessica Gilbertie, first author on this publication and former Morris Animal Foundation fellowship trainee under the mentorship of Schnabel, is working on making PRP lysate from other species, including dogs, because they also can suffer from biofilm formations related to surgical procedures.

Read this article:
New therapy could combat persistent joint infections in horses - Feedstuffs

Read More...

Experts: In rare cases, pink eye was an early warning sign of coronavirus – WTHR

Monday, April 6th, 2020

HOUSTON (KHOU11) Theres another possible symptom to add to the list of early warning signs of coronavirus.

Conjunctivitis, commonly known as pink eye, has been seen in some patients, although it's rare.

But if you have pink eye -- along with other common symptoms like fever, dry cough and shortness of breath -- you should call your doctor.

On March 30, the American Academy of Opthalmology alerted doctors that patients who need to be treated for pink eyewho also have a fever and respiratory symptoms and/or have traveled to high-risk areas -- may have COVID-19. As a result, they warned doctors to cover their mouth, nose and eyes when treating these patients, and to disinfect tools and office areas well afterward.

It isnt surprising that coronavirus could cause this symptom, Dr. Richard Watkins, infectious disease physician and professor of internal medicine at Northeast Ohio Medical University, told Prevention.

Neither the CDC nor World Health Organization has confirmed pink eye as a symptom of coronavirus.

But experts say it wouldnt be surprising.

Read more from the original source:
Experts: In rare cases, pink eye was an early warning sign of coronavirus - WTHR

Read More...

Global Opthalmology Surgical Microscopes Market with Competitive Analysis, New Business Developments and Top Companies: Carl Zeiss AG, Takagi…

Monday, April 6th, 2020

Opthalmology Surgical Microscopes Marketis expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 10.5% in the above-mentioned forecast period.The growing awareness amongst the physicians and patients regarding the benefits associated with the usage of surgical microscopes will directly impacting the growth of the opthalmology surgical microscopes market.

The major players covered in the opthalmology surgical microscopes market report are Leica Microsystems, Carl Zeiss AG, Takagi Ophthalmic Instruments Europe Ltd., Novartis, Rexxam Co., Ltd., HAAG-STREIT GROUP, Karl Kaps GmbH & Co. KG, Alltion (Wuzhou) Co., Ltd., Seiler Instrument Inc., ACCU-SCOPE, OLYMPUS CORPORATION, Global Surgical Corporation, Danaher, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Request a Sample Report of Global Opthalmology Surgical Microscopes Market @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-opthalmology-surgical-microscopes-market

Global Opthalmology Surgical Microscopes Market is the matchless market research report that conducts industry analysis on products, markets, companies, industries and many countries internationally. Market information related to specific stock, currency, commodity and geographic region or country has also been analysed in this report. Opthalmology Surgical Microscopes Market report deals with abundant parameters in detail to suit the requirements of business or clients. These parameters range from latest trends, market segmentation, new market entry, industry forecasting, target market analysis, future directions, opportunity identification, and strategic analysis to insights and innovation. All of these are analysed and evaluated by a team of innovative, enthusiastic and motivated researchers and forecasters so that nothing lefts uncovered in the Opthalmology Surgical Microscopes Market report.

Market Analysis and Insights of Global Opthalmology Surgical Microscopes Market

Increasing cases of cancer among the growing population, rising incidences of eye disorder, increasing investment for the development of technical and advanced products are some of the factors that will enhance the growth of the opthalmology surgical microscopes market in the forecast period. On the other hand, expansion of research activities will further create new opportunities for the growth of opthalmology surgical microscopes market in the above mentioned forecast period.

High cost of devices and lack of skilled professionals are acting as a restraint factor for the growth of opthalmology surgical microscopes market in the above mentioned forecast period.

This opthalmology surgical microscopes market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info onData Bridge Market Researchopthalmology surgical microscopes market contact us for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Opthalmology Surgical Microscopes Market Scope and Market Size

Opthalmology surgical microscopes market is segmented on the basis of product, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

View Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-opthalmology-surgical-microscopes-market

Opthalmology Surgical Microscopes Market Country Level Analysis

Opthalmology surgical microscopes market is analysed and market size insights and trends are provided by country, product, application and end user as referenced above.

The countries covered in the opthalmology surgical microscopes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the opthalmology surgical microscopes market due to the implementation of advanced technology and acceptance of novel technical platform.

The country section of the opthalmology surgical microscopes market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Opthalmology surgical microscopes market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for opthalmology surgical microscopes market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the opthalmology surgical microscopes market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Global Opthalmology Surgical Microscopes Market Share Analysis

Opthalmology surgical microscopes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies focus related to opthalmology surgical microscopes market.

Customization Available: Global Opthalmology Surgical Microscopes Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Buy Full Report Now @https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-opthalmology-surgical-microscopes-market

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

Go here to see the original:
Global Opthalmology Surgical Microscopes Market with Competitive Analysis, New Business Developments and Top Companies: Carl Zeiss AG, Takagi...

Read More...

Absorbable and Non-Absorbable Sutures Market Share Analysis and Research Report by 2025 – Express Journal

Monday, April 6th, 2020

Growth Analysis Report onAbsorbable and Non-Absorbable Sutures Market size | Industry Segment by Applications (Cardiovascular, Orthopedic, Gynecology, Opthalmology, General Surgery and Others), by Type (Absorbable Sutures and Non-Absorbable Sutures), Regional Outlook, Market Demand, Latest Trends, Absorbable and Non-Absorbable Sutures Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025.Analyzes current market size and upcoming 5 years growth of this industry.

A new research report titled Absorbable and Non-Absorbable Sutures market Analysis 2025 is a wide-ranging qualitative analysis of growth factors covering provincial openings, application landscape, product demand trends, and end-use portfolio of the Absorbable and Non-Absorbable Sutures industry. The report also outlines the competitive structure of the Absorbable and Non-Absorbable Sutures industry detailing the analysis and Absorbable and Non-Absorbable Sutures market share dominance of the prominent players.

As we are in the market research industry since last few years dedicated towards providing valuable insights of Absorbable and Non-Absorbable Sutures Market to business professional, industry experts, decision makers, Market consultant and other businesses. Absorbable and Non-Absorbable Sutures Market report is an extensive analysis of all available companies with their growth factors, research & methodology, Absorbable and Non-Absorbable Sutures Market Dynamics, Business Overview, Sales, Revenue, Absorbable and Non-Absorbable Sutures Market Share and Competition with other Manufacturers.

Request Sample Copy of this Report @ https://www.express-journal.com/request-sample/25254

Repot Scope:

Absorbable and Non-Absorbable Sutures market competition by top Manufacturers:

As far as the competitive spectrum is concerned, the report also enlists the information regarding the Absorbable and Non-Absorbable Sutures market growth tactics undertaken by the industry players, such as expansion strategies and mergers and acquisitions.

Absorbable and Non-Absorbable Sutures Market Outlook by Applications:

Absorbable and Non-Absorbable Sutures Market Statistics by Types:

Also, this report discusses the key drivers influencing Absorbable and Non-Absorbable Sutures market growth, opportunities, the challenges and the risks faced by key players and the market. It also analyzes key emerging trends and their impact on present and future development methodology

Absorbable and Non-Absorbable Sutures Market Report Provides Comprehensive Analysis as Following:

What Report exactly offers to the buyers

Request Customization on This Report @ https://www.express-journal.com/request-for-customization/25254

Read the rest here:
Absorbable and Non-Absorbable Sutures Market Share Analysis and Research Report by 2025 - Express Journal

Read More...

Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) – Publicist360

Monday, April 6th, 2020

Global Stem Cell Reconstructive Market was valued US$ XX Mn in 2019 and is expected to reach US$ XX Mn by 2027, at a CAGR of 24.5% during a forecast period.

Global Stem Cell Reconstructive Market

Market Dynamics

The Research Report gives an in-depth account of the drivers and restraints in the stem cell reconstructive market. Stem cell reconstructive surgery includes the treatment of injured or dented part of body. Stem cells are undifferentiated biological cells, which divide to produce more stem cells. Growing reconstructive surgeries led by the rising number of limbs elimination and implants and accidents are boosting the growth in the stem cell reconstructive market. Additionally, rising number of aged population, number of patients suffering from chronic diseases, and unceasing development in the technology, these are factors which promoting the growth of the stem cell reconstructive market. Stem cell reconstructive is a procedure containing the use of a patients own adipose tissue to rise the fat volume in the area of reconstruction and therefore helping 3Dimentional reconstruction in patients who have experienced a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in plastic or cosmetic surgeries as well. Stem cell and regenerative therapies gives many opportunities for development in the practice of medicine and the possibility of an array of novel treatment options for patients experiencing a variety of symptoms and conditions. Stem cell therapy, also recognised as regenerative medicine, promotes the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives.

The common guarantee of all the undifferentiated embryonic stem cells (ESCs), foetal, amniotic, UCB, and adult stem cell types is their indefinite self-renewal capacity and high multilineage differentiation potential that confer them a primitive and dynamic role throughout the developmental process and the lifespan in adult mammal.However, the high expenditure of stem cell reconstructive surgeries and strict regulatory approvals are restraining the market growth.

REQUEST FOR FREE SAMPLE REPORT: https://www.maximizemarketresearch.com/request-sample/54666

Global Stem Cell Reconstructive Market Segment analysis

Based on Cell Type, the embryonic stem cells segment is expected to grow at a CAGR of XX% during the forecast period. Embryonic stem cells (ESCs), derived from the blastocyst stage of early mammalian embryos, are distinguished by their capability to distinguish into any embryonic cell type and by their ability to self-renew. Owing to their plasticity and potentially limitless capacity for self-renewal, embryonic stem cell therapies have been suggested for regenerative medicine and tissue replacement after injury or disease. Additionally, their potential in regenerative medicine, embryonic stem cells provide a possible another source of tissue/organs which serves as a possible solution to the donor shortage dilemma. Researchers have differentiated ESCs into dopamine-producing cells with the hope that these neurons could be used in the treatment of Parkinsons disease. Upsurge occurrence of cardiac and malignant diseases is promoting the segment growth. Rapid developments in this vertical contain protocols for directed differentiation, defined culture systems, demonstration of applications in drug screening, establishment of several disease models, and evaluation of therapeutic potential in treating incurable diseases.

Global Stem Cell Reconstructive Market Regional analysis

The North American region has dominated the market with US$ XX Mn. America accounts for the largest and fastest-growing market of stem cell reconstructive because of the huge patient population and well-built healthcare sector. Americas stem cell reconstructive market is segmented into two major regions such as North America and South America. More than 80% of the market is shared by North America due to the presence of the US and Canada.

Europe accounts for the second-largest market which is followed by the Asia Pacific. Germany and UK account for the major share in the European market due to government support for research and development, well-developed technology and high healthcare expenditure have fuelled the growth of the market. This growing occurrence of cancer and diabetes in America is the main boosting factor for the growth of this market.

The objective of the report is to present a comprehensive analysis of the Global Stem Cell Reconstructive Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Stem Cell Reconstructive Market dynamics, structure by analysing the market segments and projects the Global Stem Cell Reconstructive Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Stem Cell Reconstructive Market make the report investors guide.Scope of the Global Stem Cell Reconstructive Market

DO INQUIRY BEFORE PURCHASING REPORT HERE: https://www.maximizemarketresearch.com/inquiry-before-buying/54666

Global Stem Cell Reconstructive Market, By Sources

Allogeneic Autologouso Bone Marrowo Adipose Tissueo Blood Syngeneic OtherGlobal Stem Cell Reconstructive Market, By Cell Type

Embryonic Stem Cell Adult Stem CellGlobal Stem Cell Reconstructive Market, By Application

Cancer Diabetes Traumatic Skin Defect Severe Burn OtherGlobal Stem Cell Reconstructive Market, By End-User

Hospitals Research Institute OthersGlobal Stem Cell Reconstructive Market, By Regions

North America Europe Asia-Pacific South America Middle East and Africa (MEA)Key Players operating the Global Stem Cell Reconstructive Market

Osiris Therapeutics NuVasives Cytori Therapeutics Takeda (TiGenix) Cynata Celyad Medi-post Anterogen Molmed Baxter Eleveflow Mesoblast Ltd. Micronit Microfluidics TAKARA BIO INC. Tigenix Capricor Therapeutics Astellas Pharma US, Inc. Pfizer Inc. STEMCELL Technologies Inc.

MAJOR TOC OF THE REPORT

Chapter One: Stem Cell Reconstructive Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Stem Cell Reconstructive Market Competition, by Players

Chapter Four: Global Stem Cell Reconstructive Market Size by Regions

Chapter Five: North America Stem Cell Reconstructive Revenue by Countries

Chapter Six: Europe Stem Cell Reconstructive Revenue by Countries

Chapter Seven: Asia-Pacific Stem Cell Reconstructive Revenue by Countries

Chapter Eight: South America Stem Cell Reconstructive Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Stem Cell Reconstructive by Countries

Chapter Ten: Global Stem Cell Reconstructive Market Segment by Type

Chapter Eleven: Global Stem Cell Reconstructive Market Segment by Application

Chapter Twelve: Global Stem Cell Reconstructive Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Stem Cell Reconstructive Market Report at: https://www.maximizemarketresearch.com/market-report/global-stem-cell-reconstructive-market/54666/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Visit link:
Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Publicist360

Read More...

The rise of ‘rich woman face’: how to halt the ageing process (for a certain price) – Telegraph.co.uk

Monday, April 6th, 2020

'Let me tell you about the very rich,' wrote F Scott Fitzgerald. 'They are different from you and me.' Above all, in the lengths they will go to acquire, and preserve, perfect skin.

Sheikha Moza bint Nasser, the consort of the former Emir of Qatar, may well be the richest person I've ever met. She certainly has skin like no one else on the planet. She's 61 but looks about 40, with a face that seems to have no visible pores, perhaps because it's sculpted out of alabaster.

Admittedly, she is carefully made-up on a regular basis, so she would have been unlikely to want to attend a recent dinner party of Gwyneth Paltrow's in Beverly Hills, at which guests were banned from wearing any cosmetics at all. Kate Hudson and Demi Moore were among those who gamely took the challenge, the idea of which was to allow the assembled LA A-listers to show off their natural glow.

But they don't, of course, rely wholly on nature for their radiance. Moore's evening beauty routine (pared back to the minimum because, she says, "I like to keep it simple") includes eight separate products, with a total cost of 743.50, from a cleansing elixir to a 355 replenishing facial oil and a rose-quartz facial massager in the shape of a butterfly.

No wonder that, far from being petrified at the thought of the make-up-free dinner, she felt 'full of joy', according to her Instagram posts. Her face wasn't coated in foundation, but it was insulated by a thick layer of cash.

With skincare that promises actually to reverse the visible signs of ageing, beauty brands feel entitled to charge impressive sums. La Prairie has one serum, its Platinum Night Elixir, that sells for over 1,000 for 20ml. It costs about 10 more per gram than solid gold. Imagine if your cat knocked that one off the dressing table.

On the other hand, the scientist who developed it says the peptides and amino acids contained in a single daily drop will leave your skin visibly younger-looking and fresher in two weeks. Users say it feels like wrapping your face in cashmere.

La Prairie Platinum Rare Cellular Night Elixir 20ml, 1,018, Harvey Nichols

I rely on Dr Phillip Levy, a Swiss dermatologist and wound-healing specialist based in Geneva, whose moisturisers and serums are proven to revitalise dermal stem cells to kick-start your skin's own production of collagen. Another doctor - German-born Michael Prager, who operates from a clinic in Wimpole Street - emphasises the rejuvenating effects of combating pollution with an antioxidant cream that fights off free radicals.

Neither of these medical-grade ranges comes cheap, but though Dr Prager's day oil contains pure gold, at 225 for 30ml (drmichaelprager.com), it's not actually as expensive as buying the precious metal itself.

If you're going down the Sheikha Moza route to moneyed perfection with a lavish use of make-up, Gucci Westman is a name to conjure with. This make-up artist, who has worked with Natalie Portman and Nicole Kidman, has her own range, Westman Atelier.

Lip suede in Les Rouges, 75, Westman Atelier (net-a-porter.com)

Yes, the colours are lush but, even better, the brand is 'clean' - beauty-speak for vegan, against animal-testing, paraben-free and so on. Plus, the products moisturise, plump up collagen and soothe as you apply them. Even the mascara conditions your lashes. So what if it costs 58?

Equally impressive is Shiseido's luxury line, Cl de Peau, which does a foundation that's 250 for 27ml, in 13 shades. Again, it's a beauty treatment with SPF and moisturiser as much as a make-up product, and it's what I'll put on if I want anyone to tell me I look glowing.

But, of course, more precious than any cream or blush stick is a little personal attention. Dr Costas Papageorgiou operates out of Harrods and has fairly expensive-looking skin himself. He makes use of a battery of lasers, Botox, fillers and ultrasound, but the key to his success is the consultation that starts off the process.

The Foundation,250, Cl de Peau Beaut (harrods.com)

Seeing your own face in unforgiving 3D on a computer may be a shock, but it certainly helps pinpoint the areas you'd like him to focus on. He's very hot on correcting facial symmetry, which starts out pretty good in babies, but with time and use, the muscles on the face become less symmetrical as bits start to droop or wrinkle. Generally, the more lopsided you are, the more antique you look, and he can address that with filler, Botox and even thread lifts.

But I'm not one for the injectables. It's his Hybrid Energy Lift - a combination of ultrasound, infrared, light and laser - that I really rate (from 6,000 for 120 minutes, facialplasticslondon.com). It, too, stimulates collagen production, but it also gets rid of visible veins and redness, and even reduces big pores. I have had to change the tone of my foundation for a paler one since he did for my (mild) rosacea.

Radical3 Reboot Pro Peel, 89, Dr Levy (editorslist.co.uk)

The key, says Dr Papageorgiou, is to delay and reverse the "ageing cascade". This slow car crash of fine lines around the eyes, sun damage and heavy jowls is all thanks, he says, to "fat atrophy and bone resorption".

But subtlety is all - "A great result is one that shows no signs of intervention"- and nothing, he warns, can really be achieved unless you have a healthy diet, exercise and take vitamins.

Debbie Thomas, at her D.Thomas clinic in London, has a similarly personalised approach. You don't book in for a single treatment, you book for an hour of her expert time, and she'll use a cocktail of lasers, micro-needling and products depending on what you need (475 for a DNA Laser Complete 2 session, dthomas.com).

"I'm afraid,"she says, "traditional facials are not going to transform your skin for more than a few days. You need to upgrade to more advanced treatments if you want long-term results. And those will be more costly."And who can say it's not worth the money?

Sign up for theTelegraphLuxury newsletterfor your weekly dose of exquisite taste and expert opinion.

See more here:
The rise of 'rich woman face': how to halt the ageing process (for a certain price) - Telegraph.co.uk

Read More...

The New New Math: Inside the Russian School of Mathematics – Boston magazine

Monday, April 6th, 2020

K-12 Education

It touts itself as the key to helping your child get a leg up at school and presumably into college. Is this just the latest case of wealthy suburbanites keeping up with the Joneses, or has a Russian woman in Newton figured out a better way to teach to American kids?

Russian School of Mathematics cofounder Inessa Rifkin started teaching kids extra math at her dining room table in Newton more than 20 years ago. Today, the program has 40,000 students in 53 schools in 12 states, Washington, DC, and Canada, in addition to a booming online program. / Photo by Jason Grow

On a January afternoon at the Russian School of Mathematics headquarters, a 6,500-square-foot bilevel brick building in a Newton corporate office park, Inessa Rifkin leads 15 excitable third and fourth graders through a lesson on graphs. She is in her sixties and chic in a blue-gray tunic over a crisp white button-down, skinny black pants, and a Tiffany-style silver pearl necklace. When she asks a question, her Russian accent unflinching, more than half of the students put their hands in the air. Not a single one has a cell phone on his or her desk. No ones staring into space.

About halfway through the two-hour class she asks, Quiz or break? The group is unanimous in its decision: Quiz it is!

For Rifkin, there are two reasons to celebrate: Not only have the kids willingly chosen a quiz, but just before class began shed learned that the Russian School of Mathematicsthe extracurricular K12 program she cofounded with fellow Soviet Union expat Irina Khavinson in Newton 22 years agohad surpassed 40,000 students. RSM has 53 locations in 12 states, Washington, DC, and Canada. Online classes already have students from 24 countries, and are growing faster than Rifkins son, Ilya, who is the CEO, can find qualified teachers to teach them.

As the schools birthplacebut also as a particular hotbed of do-more, get-ahead parentingMassachusetts is ground zero for Russian Math. Inessa Rifkin estimates that one in four elementary students in Lexington is enrolled in her after-school program; the majority of kids start in second grade and continue through at least eighth, though many go all the way through high school. I remember we couldnt believe it when we got 40 students that first year, she says. Back then, she held classes around her dining room table, and the neighbors complained about the lines of cars coming and going. These days, RSM employs a traffic cop to help keep order during pickup and drop-off at the schools flagship location, which can accommodate several hundred kids at any given time. We never even considered ourselves businesswomen, Rifkin says of herself and Khavinson, acknowledging that they didnt have a proper business plan until 2009, when Ilya quit his job at a Manhattan hedge fund to join the company at his mothers urging. And in this business plan, he wrote we would reach 10,000 students, Rifkin says. I laughed. Ten thousand students? From where?

A decade later, Russian Math is nothing short of a phenomenon. Rifkin and Khavinson have been approached by eager VCs several times over the past 20 years to invest or buy them out and have turned down every offer. Parents of students in Russian Math, meanwhile, note with pride that their kids are two or three years ahead of their peers in math at school, and the company boasts of students remarkable scores on standardized tests (a 774 average math score for juniors who take the SAT) and high GPAs in school. The lobby at HQ displays photos of alumni alongside their recent college acceptances: Brown, Dartmouth, MIT, Georgetown.

Still, not everyone thinks the program is the best thing thats happened to math education since flashcards. Critics say it has questionable academic value to children and is focused more on accelerating students than deepening their understanding of the material. Whats more, theres growing concern that the significant proportion of students enrolled in Russian Math in some Boston suburbs is having a negative effect on the learning environment inside regular school classrooms. Some see RSM as less of a mathematical miracle and more of an example of savvy marketing colliding headlong into suburban parental panic. In a prior age, if your child was having trouble in math, youd hire a tutor, if you had the money, says Jon Star, an educational psychologist at Harvard who researches math education. But all these kids who are going to Russian Math arent going there because theyre having trouble in math. Theyre going there because the public school is not going fast enough for what parents perceive their child needs. So its just a very different set of motivations.

Such behavior can put even more pressure on kids who are already feeling unprecedented levels of anxietyand on parents to keep up with one another, either for perception or for something to talk about at dinner parties. Newton mother of three Marcela Almeida, whose oldest child started at RSM in third grade, her middle child in first, and her youngest in kindergarten, found herself smack dab in the middle of the rapidly accelerating suburban mathematical arms race. She says she enrolled her kids in RSM even before shed decided there was anything particularly wrong with the education they were getting for free at the public schools. I felt a tremendous pressure from our community to send our kids to RSM, she says. It appears as though attending RSM is the norm where we live, so I didnt want them to be behind.

Irina Khavinson worked as a math teacher for 15 years in St. Petersburg before teaming up with Rifkin to found the Russian School of Mathematics. / Photo by Jason Grow

Rifkin came to the United States from the Soviet Union with her husband, Victor, and their two kids, Ilya and Masha, with eight suitcases and $90 in 1988. She got a job as a mechanical engineer at Kronos, a maker of labor-management software. Ilya was in eighth grade when Rifkin says she started to question his motivation in school. His grades were fine, but not great; she assumed he was being lazy. So I looked at what he was learning, she says. The math wasnt up to my standards. He did not know things I thought he should know by then. The lessons lacked cohesive flow; they were disconnected from one to the next and the process focused more on getting to the correct answer than understanding how to get there. No wonder Ilya wasnt motivated, she thought, and of course he and his friends all hated maththe material was prescribed, rote, and very dull. Rifkin started talking to other parents. Slowly, I came to the realization that its not that hes lazy, she says. He takes advantage of everything thats offered to him. But not much is offered to him.

Rifkin started tutoring her son and some of his friends after work using lessons she remembered from an elite mathematics school that shed attended in Minsk. The kids seemed to respond, and she began to think of ways to offer lessons to even more students, envisioning a structured program with teachers who would demand respect from their students and a math curriculum that would make learning funand effective. Not something where someone comes to your house and your child feels like, My parents pay you money so you do what I tell you to do, which could not be more American, she says.

Her first step: Find a teacher. I started to ask around, Who knows good teachers from back in the Union? she says. In response, a few people told her that somebody told them that somebody had mentioned a woman named Irina. Then 47, Khavinson had been a math teacher for 15 years in St. Petersburg, then known as Leningrad. In Boston, she was working as an accountant and tutoring kids on the side, using a mix of Russian textbooks and lessons shed developed on her own.

In December 1997, not long after teaming up, Khavinson and Rifkin advertised a meeting at Temple Beth Elohim in Wellesley to talk about the state of their childrens math education. Six hundred people showed up, mostly Russian-Jewish immigrants. Rifkin stood before them and presented her idea for the Russian School of Mathematics. She talked about building a community based on a common need, a place where kids could learn math and play together, and parents could get acquainted with one another. She didnt have to explain to fellow Russians why math was important. To them, Rifkin says, math is what puts minds in order. Whats more, for immigrant families, STEM is considered a lifeline and the pathway to success in the United States. I said, We know what good mathematics is. Lets try to do that here for our kids, she recalls. One Newton mom, Olga Dadasheva, stood up and said she recognized the problem, but asked what made Rifkin think she was the one who could solve it. And I said to her, Rifkin recalls, You pretty much dont have any other choice but to let me try.

Dadasheva, who arrived in the U.S. from Moscow in 1989 and was working as a software developer, had been looking for math tutoring for her daughter, who was 12 at the time. Its easy to criticize American education in general, Dadasheva says now. But Russians in particular have this experience where it has to be hard at school. You have to work very hard and get great marks. And that was missing in American schools, where it was more like, If you can do it, thats great. If you cannot do it, thats great, do it tomorrow.

That night at the temple in Wellesley, Rifkin and Khavinson convinced 60 students to commit, all children of Russian immigrants. Says Rifkin: It was less a business than a movement.

Once RSM students (and their peers) started to see the edge they had over the other kids in school, and the confidence that resulted, more kept comingRussian students, but also children of Chinese and Indian and European immigrants, too. By February 1998, Rifkin had quit her job at Kronos, and by September of that year, RSM had enrolled 150 students and moved to its first commercial location on Beacon Place in Newton, a two-room space on the second floor, over a hair salon. In 1999, Rifkin took out a home equity loan to buy a small white house with blue shutters on busy Centre Street, onto which her husband installed a large sign that read, The Russian School of Mathematics. It was all the advertising they needed, Rifkin says. In no time, the first Americans started showing up.

Biotech entrepreneur Heidi Wyle was one of them. She and her husband had moved to Weston for the good public schools, she says, but teachers were not teaching math the way she thought they should. We used to joke that in the Weston schools, it was like, No child allowed ahead, says Wyle, whose children are now grown and in their twenties. They were happy to handle the kids who needed help, but they didnt want these kids who were really bright.

Wyle was instrumental in introducing RSM to her circle of high-powered, highly educated friends, which included several parents who were professors at Harvard and MIT. But a 2001 article that ran on the front page of the Boston Globe, A Russian Solution to a U.S. Problem, was the key to drawing in American families en masse, Rifkin says. The writer basically drove by on a Sunday morning and saw these kids playing outside the house, she recalls. He stopped and asked a very cute kid, What are you doing here? And the kid said, Im studying math. He said, Youre studying math on a Sunday morning? Why? And the kid said, Because I want to get smart and go to MIT. The morning after the story ran, Rifkin arrived at the little house on Centre Street to find a line out the door.

Teacher Irena Burmistrovich instructs a classroom full of engaged students. / Photo by Jason Grow

From the start, Rifkin and Khavinson developed the RSM curriculum in-house, taking some of what Rifkin had used to teach Ilya and some of what Khavinson had used with her students, and then put the first round of tuition payments they received into further developing the coursework. They relied largely on the network of parents gathered that night at Temple Beth Elohim to find Russian migrs, many of whom worked in academia, to help create lesson plans that emphasized critical thinking and reasoning over memorization. Advanced concepts, such as algebra, were introduced as early as first grade, using age-appropriate approaches and lots of visuals, because according to Rifkin and Khavinson, studies show that kids who learn algebra at an early age have better cognitive development overall. They encourage students to reach calculus by 10th or 11th grade.

Still, Rifkin and Khavinson argue their strategy is not as simple as merely giving students next years work. The main difference between Russian Math and the math being taught in schools, they say, boils down to a methodology that emphasizes derivation over memorizationof learning the reasons behind the answersand a visual approach that helps students see the math, and therefore understand it better. Russian Math students also put in more face time with teachers: Since most kids sign up for 90 minutes to four hours a week in concentrated blocks, they theoretically get a chance to understand concepts more deeply. Classes are smaller, too, averaging around 12 students, and divided by ability levels, which means that teachers can teach to students very specific needs in a way that public school teachers just cant. Its almost like how you do athletics here, Rifkin says. Its not for your child to become an Olympic finalist. Math for us is not to become a mathematician, but to become a good thinker.

Wyle, whose kids had also tried the math-enrichment program Kumon but quickly lost interest, remembers being impressed the first time she took her then-first grader to sit in on an RSM class. They were doing algebra, she says. And the way they did it would be, like, two kids balanced on a seesaw. And underneath one kid, there might be the number seven, and underneath the other kid and a weight is a number five. And then they would ask the students, What does the weight weigh? and of course the kids would say two because they could see it, right? Their whole approach was built around seeing the math, and I myself could sort of see quantum mechanics by the time that class was over. They were teaching kids to see and understand. Not just do.

Most important, students seem to like it. Newton mom Ellen Chu and her husband initially enrolled their daughter in RSM because she told them she hated math. This year, she started her first year of college at Oxford, majoring in math and computer science. I think my daughter came to love math because RSM introduced her to more-complex, nuanced math, which she found exciting, Chu says. Based on her experience, I think the school is trying to help its students think, problem-solve, and enjoy math.

Meanwhile, Wyle says RSMs teachers are warm and invested and create a tightknit community. Even from the very early days, she recalls, when the kids got high SAT scores, when they were merit finalists or stuff like that, for the teachers, it was like our kids were their kids.

Make no mistake, Russian Math can be an adjustment, especially for students who start when theyre older. Four hours of extra math every week is a lot, and theres homework, too. Maria Rubio, whose two daughters attended RSMs Framingham and Wellesley locations and who first heard about the program from a Polish mom at her kids bus stop, says her older daughter was moved up a level at RSM after a teacher there said she wasnt being challenged enough. The first year, the poor girl, Rubio says. They would give her stacks of hundreds of exercises just so she could catch up. Rubio asked the teacher if she was really sure her daughter was ready. She told me, Im not going to keep her in the lower class because, I mean, this is about challenging them, Rubio recalls. This is not about anything else. She doesnt belong there. She has to go to the other level. So she struggled but she made it and she became really, really fluent and now I always thank those big stacks of exercises.

In another success story, Belmonts Alanna Fincke sent her son to Russian Math last year as an eighth grader at his request. For Jonah, the way they taught made more logical sense to him than the way it was taught in his public school, Fincke says. Hed previously attended, and liked, Kumon. And yet, Fincke says, There was something about Russian Math that just seemed like a challenge, and he really liked that.

All of the kids I talked to said Russian Math puts them at an advantage in their regular math classes, where they tend to do better on testsor, at least, they dont have to study as hard to do okay. Rifkin believes that better grades arent all theyre getting: Grades matter, but theyre also more confident, she says. I see this in the girls we teach, especially. They enjoy their smartness tremendously. Theyre not shy of being smart, or of having a voice in class. I see them when they start with us and I see them when they leave us and theyre different people.

Photo by Jason Grow

Not everyone is convinced, though, that there is anything particularly special going on at Russian Math, other than kids spending four hours a weekor moreworking on arithmetic. (In Jonahs case, his parents even hired a tutor to help him do better in Russian Math, which may be the next level of the mathematical arms race.) Parents may think it is helping their kids, but Harvards Jon Star says there is no evidence that enrollment in RSM translates into better grades in schools or better standardized test scores. Whats more, he takes issue with the idea that Russian math is somehow better than the math thats taught in public schools. In fact, he doesnt even think its demonstrably unique. Part of the RSM sales pitch, Star says, is that its coursework engages students more, and differently, than their normal school curriculum. But he says theres no universal school of math in Russia that everyones following and that is significantly different from what is taught in the U.S. Id urge parents to be cautious with that claim, he says, because just because the teacher teaches math while speaking with a Russian accent doesnt make it better.

What Star suspects is really going on is that Russian Math is merely teaching kids the same math they learn in their regular curriculum, just earlier and fasterwhich he says is pretty low-hanging fruit in the world of math education.

Meanwhile, Hilary Kreisberg, director of the Center for Math Achievement at Lesley University and a former fifth-grade teacher turned math coach, says her experiences with RSM students have led her to question the claim that Russian Math focuses more on developing a deep understanding of math instead of memorization. In fact, she has seen the opposite. From what Ive seen, they come in well above their grade-level standards in terms of memorization, but not in terms of content understanding, she says. Many of them very quickly get to an answer or can compute in a fast way, but they cant necessarily explain to me what theyre doing or why theyre doing it. And explanations, she says, are a critical component of mathematics. In public school teaching, we are very strictly taught that the goal is not to accelerate, Kreisberg says. The goal is not to extend their thinking into another grade level, but to go deeper with the current grade-level standards because theres always more you could learn about a topic.

Many parents, though, love the accelerated curriculum and feel it gives their kids an edge, not just in high school but in the ever more competitive quest for admission to an elite university. Every last one of the dozen-plus RSM parents I spoke with told me that their child was way ahead of their regular math class, which they viewed as evidence of a less-than-challenging curriculum and further proof of how far behind American math is.

Star and Kreisberg say this attitude is part of a misguided race to calculus, where the view is that the sooner a student gets there, the better. Its not about helping your kid get to where they should be in math to really understand the math deeply. Its about going fast so you can get ahead of everyone else, with the perception that that helps. And for what? Star asks. There is zero evidence that it helps your child to take calculus in 10th grade.

Parents of RSM students note with pride that their kids are two or three years ahead of their peers. / Photo by Jason Grow

Not surprisingly, the popularity of Russian Math has posed a significant challenge for schools, whose teachers now find themselves struggling with how to instruct an increasing number of students whove already seen the material. The range in students abilities in a single classroom has always been a hurdle for educators. Now that rangeand the challengeis far bigger.

Ultimately, it isnt just an issue for teachers, but for the very kids who attend RSM. Many of them are bored in math class and have lost their curiosity, Kreisberg says, which is an essential part of math. My experience with students who have engaged in Russian Math is that they oftentimes have this arrogant disposition of, I already know this, I dont need to learn it again, even though they might be missing foundational gaps because theyre so accelerated. She continues, They dont want to learn a different way to solve something. They just want to get to the answer because they can. I have a harder time teaching those students than any other students that I work with.

It isnt just RSM kids whose learning in school is affected, but non-RSM kids, too, who begin to question their abilities even if theyre performing perfectly well at grade level. Kreisberg says that when RSM kids in class make rapid-fire calculations, the other students begin to feel theyre not good at math, and that to be good they need to be in the RSM program.

In the worst cases, the Russian Math kids are rude and disrespectful to their teachers. Chu recalls hearing her daughter describe a situation at her high school in which RSM students were constantly correcting and criticizing their regular school teacher. The word my daughter used, Chu says, was insufferable.

Kreisberg views the popularity of Russian Math as representative of a general lack of respect for teachers. Who determines if a child is too advanced for their regular school curriculum? she says. Its usually the parents, who are not qualified educators. But theyre not going into hospitals and telling doctors, Hey, you should use this more-advanced procedure because I read about it somewhere. Nobody questions what we do in medicine, but we question educators all the time because we dont value our teachers. While thats likely not entirely truemedical professionals have complained about this very problem since the first season of ERseveral parents did admit that they enrolled their children in RSM without ever bothering to talk to their kids school. We realized early on that the school didnt have accommodations for our daughters specific level, Rubio says. But we never asked the school about it. Because we had RSM.

At the same time, many RSM parents and students seem to expect teachers to teach to their accelerated level, and at least some schools seem to be complying. According to RSM, Newton South has added new courses and additional levels of math or provided RSM kids with extra homework in order to keep these kids engaged (and their parents happy).

In most cases, though, teachers dont teach to the RSM kids accelerated levels, presumably because theyre busy teaching the rest of the students who are learning on the normal public school schedule. Rubio says one of her daughters was separated out of class for a year. They would give her a packet with some supposedly more-advanced stuff, and she would go out into the hallway with another girl and do work together, she says. And I said, But what do you do if you have a question? And she would say, Oh, I just ask [the other girl]. And I said, What if she has a question? And she said, She asks me.

RSM also says that other towns, including Weston and Winchester, are taking more-extreme measures. They have started specifically asking parents to refrain from enrolling their children in the Russian School of Mathematics, something that only seems to spark more ire among parentsand which gets tricky when teachers from those districts are spotted dropping off their own kids there. (None of the schools mentioned in this article, nor many others contacted for this story, responded to repeated requests for comment.) Star thinks schools could do a better job communicating their plan for attending to advanced childrens math instruction needs, instead of just discouraging enrollment in RSM. But maybe in some communities, he says, it already feels like they lost the battle.

There is also the issue of elitism. RSM says that classes start at $20 an hour, which may be a handy way of making it sound affordable; tuition for most students is at least $2,000 per course. It is likely not a coincidence that its locations are all in upper-middle-class towns. According to a 2019 report about after-school math from Pioneer Education, all but one of the Massachusetts towns where RSM has locations have a median household income of $93,600 or more, compared to the statewide average of $67,800; five are among the 20 Massachusetts communities with the highest median income. While Kumon has partnered with schools in inner cities to provide its program to low-income families, RSM has no similar program. (It does, however, offer financial aid to 10 to 15 percent of its students.)

Chu says that in middle school, her daughters teachers were openly critical of RSMs elitist nature, and Chu doesnt disagree with them. Neither does Wyle, saying, I understand why [the schools] would have that defensive position, because its tough for them when they have some significant cohort in their class who are getting this world-class math education, and then theres everybody else. But from my perspective, I never would have been at the Russian School of Mathematics if it hadnt been for Westons bad math curriculum.

On a Saturday morning in late January, the lobby at RSMs Newton headquarters has become the new soccer-field sidelines: Moms in Canada Goose parkas chat animatedly, clutching Yeti mugs, as sleepy kids shuffle into their respective classrooms. The parking lot is a showroom of Range Rovers and white Audis. My God, we spent so much money on it, says mom Maria Rubio of the years her two daughters attended RSM. But it is amazing.

Continued here:
The New New Math: Inside the Russian School of Mathematics - Boston magazine

Read More...

Your Mind Is the Most Important Factor in Successful Investing – Nasdaq

Monday, April 6th, 2020

Investment icon Warren Buffett once said, "Success in investing doesn't correlate with IQ ... what you need is the temperament to control the urges that get other people into trouble in investing." In other words, it's not about being smart, it's about how you think. Warren Buffett actually learned that from value investing legend Benjamin Graham, who was extolling the importance of emotion in investing before Buffett bought his first stock. In fact, there's now a whole branch of finance that looks at this issue, called behavioral finance. It's basically a blend of psychology and finance that examines all of our all-too-frequent mental mistakes. You make them -- but we all do.

If you want to be a successful investor, you need to understand these misconceptions. Here's a primer on why your mind is the most important factor in investing.

If you ask a room full of people if they are above-average drivers, almost everyone will raise their hand. That's statistically impossible, since roughly half have to be worse than average. This is anecdotal, but it gets to the heart of the matter. We all think we are better than we really are. And in investing that's a big blind spot, and one that will often lead you astray.

Image source: Getty Images

This isn't to suggest that you (yes, you specifically) aren't smart and capable. It's just that you are likely to overestimate just how smart and capable you are. That will lead you to believe that what you are doing is right without question. In other words, although terribly cliche, the first thing you need to do is admit you have a problem. And once you do that, you can start to look at ways that you might be wrong about your investment decisions.

This, however, never ends, because you will be human all of your life. So you'll need to be on guard forever. Getting "you" right is a lifetime effort.

The human mind has two broad ways of thinking. One is slow and calculated, the other quick and emotional. By nature we tend to use the quick way most often. It makes sense -- if there's a car bearing down on us as we cross the street, we can't sit around and contemplate what to do. Investing, however, requires us to move past quick decisions and use the vast processing power of our minds. Sounds easy, but when we're under stress we usually revert to quick, emotional thinking. Investing is stressful even on a good day. (Today, with COVID-19 pushing us into a bear market and likely into a recession, it's even more stressful than usual.)

You need to make changes to your process so you limit the stress and give your calculating mind time to work. For example, you might stop placing trades during market hours, and instead set up your trades before or after the market closes using limit orders. That way you don't feel pressure to act. Or instead of watching the market every second looking for a stock to buy, look at companies and create a list of names you'd like to own. After you have that list, figure out the prices you'd be willing to pay, and only buy them at those prices. You get the idea -- pull yourself out of high-stress situations and you'll give yourself the space to make better choices.

You make mistakes, we all do. It's actually a good thing, because it's the way human beings learn. That, however, doesn't mean you should accept mistakes, especially since we're prone to making the same ones over and over again.

If you like big dividend yields, for example, you'll probably find yourself attracted to companies where the dividends are at severe risk of being cut. Kinder Morgan (NYSE: KMI), for example, had a yield in the double digits before it cut its payout in 2016 because its aggressive use of leverage limited its access to capital in a difficult energy market. The midstream giant is still trying to rebuild trust with investors.

If you find value stocks attractive, you'll probably find yourself looking at stocks that are cheap for a reason. Sears Holdings had iconic retail names and owned a huge collection of physical properties, but none of that allowed it to avoid the fact that the retailer was increasingly falling behind peers. It ended up in bankruptcy court, effectively wiping out equity investors.

And if you think growth is the best way to go, you'll likely have to stop yourself from buying wildly overpriced shares driven by nothing more than a wish and prayer. There are any number of manias that can be used to illustrate this one, but one of the best is internet stocks in the late 1990s. Booking Holdings (NASDAQ: BKNG) is a good example. It went public under the Priceline name in 1999 at the peak of the hype, rocketed higher, and then lost 99% of its value over the next two years. It was a real business, and still is, but it took roughly a decade for the stock to get back to its IPO price after that decline. Obviously, there was too much hope and hype in the price when the stock came public.

If you know your investment style, then you need to figure out what can go wrong with that style. For example, Bruce Berkowitz, the manager of Fairholme Fund, has a list of things that companies often do that lead to disaster. He is, essentially, trying to kill a company before he buys it. The list includes things like taking on too much debt and spending more cash then a business can generate.

There are three big takeaways from this list. One, Berkowitz examined his process and figured out where he often goes wrong -- recognizing that he isn't infallible. Two, he created a list to test his decisions -- questioning himself before he acts. And three, the list forces him to slow down and work outside of the pressure cooker that is Wall Street -- removing the intensity of time constraints.

These are just three points to consider, but they cover a lot of ground. And they get to the heart of the matter. You are your own worst enemy when it comes to investing. In fact, you will dramatically improve your investment performance simply by limiting the mistakes you make. It isn't an easy journey, but it's one that good long-term investors have to go on at some point. If you don't, you'll continue to make the same mistakes over and over again, and your investment results will suffer for it.

But you have the power to do something about. First admit that, when it comes to investing, you have a problem -- and it's you.

10 stocks we like better than Kinder MorganWhen investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Kinder Morgan wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of March 18, 2020

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Booking Holdings and Kinder Morgan. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Excerpt from:
Your Mind Is the Most Important Factor in Successful Investing - Nasdaq

Read More...

Global Nerve Repair and Regeneration Industry – GlobeNewswire

Monday, April 6th, 2020

New York, April 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nerve Repair and Regeneration Industry" - https://www.reportlinker.com/p05799212/?utm_source=GNW 3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$11.8 Billion by the year 2025, Neurostimulation & Neuromodulation Devices will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$339.2 Million to the regions size and clout in the next 5 to 6 years. Over US$405.8 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Neurostimulation & Neuromodulation Devices will reach a market size of US$527.3 Million by the close of the analysis period. As the worlds second largest economy and the new game changer in global markets, China exhibits the potential to grow at 16.1% over the next couple of years and add approximately US$1.4 Billion in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p05799212/?utm_source=GNW

NERVE REPAIR AND REGENERATION MCP13MARKET ANALYSIS, TRENDS, AND FORECASTS, FEBRUARY 2CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. GLOBAL MARKET OVERVIEW Nerve Repair and Regeneration Market Set for a Rapid Growth Neurostimulation and Neuromodulation Devices: Largest Product Segment Biomaterials to Exhibit Rapid Growth Nerve Repair and Regeneration Market by Application US and Europe Dominate the Market, Asia-Pacific to Register the Fastest Growth

2. FOCUS ON SELECT PLAYERS Abbott Laboratories, Inc. (USA) AxoGen, Inc. (USA) Boston Scientific Corporation (USA) Integra LifeSciences Corporation (USA) LivaNova, PLC (UK) Medtronic plc (USA) NeuroPace, Inc. (USA) Nevro Corporation.(USA) Orthomed S.A.S. (France) Polyganics B.V. (The Netherlands) Stryker Corporation (U.S.) Synapse Biomedical Inc. (U.S.) Synovis Micro Companies Alliance, Inc. (USA)

3. MARKET TRENDS & DRIVERS High Incidence of Brain Disorders and Nerve Injuries: Primary Market Driver EXHIBIT 1: Annual Incidence of Adult-Onset Neurologic Disorders in the US EXHIBIT 2: Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy EXHIBIT 3: Global Alzheimer's Prevalence by Age Group EXHIBIT 4: Diagnosed Prevalence Cases of Parkinsons Disease Across Select Countries Classification of Nerve Injuries Recent Developments in Spinal Cord Injury Treatment Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders EXHIBIT 5: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2and 2050 Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury Innovative Nerve Conduits from Stryker Technological Advancements and Product Innovations - A Key Growth Driver Neurostimulation Allows Paralyzed People to Regain Leg Movement Neurostimulator to Treat Neurological Conditions Micro-Implantable Solution for Neurostimulation Parasym Device for Neurostimulation Boston Scientifics Spinal Cord Stimulation Improves Quality of Life Intellis Platform Presents Smallest Implantable Neurostimulator Innovation in Deep Brain Stimulation for Parkinsons Disease Innovations in Spinal Cord Stimulation for Pain Smart Neuromodulation: The Combination of AI and Neuromodulation Technologies New Dynamic Lead Interface Design for Neurostimulator Devices Wireless SCS Neuromodulation Therapy: An Alternative to Traditional SCS System Select Recent Approvals of Neuro-stimulation and Neuromodulation Devices Select Launches in Spinal Cord Stimulation (SCS) Market Select Launches in Deep Brain Stimulation (DBS) Market Select Neurostimulation Devices in Clinical Trials Select Neuromodulation Devices in Clinical Trials

4. GLOBAL MARKET PERSPECTIVE Table 1: Nerve Repair and Regeneration Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 2: Nerve Repair and Regeneration Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 Table 3: Nerve Repair and Regeneration Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 Table 4: Neurostimulation & Neuromodulation Devices (Product) World Market by Region/Country in US$ Thousand: 2018 to 2025 Table 5: Neurostimulation & Neuromodulation Devices (Product) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 Table 6: Neurostimulation & Neuromodulation Devices (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 Table 7: Biomaterials (Product) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 Table 8: Biomaterials (Product) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 Table 9: Biomaterials (Product) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 Table 10: Neurostimulation & Neuromodulation Surgeries (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 11: Neurostimulation & Neuromodulation Surgeries (Application) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2009-2017 Table 12: Neurostimulation & Neuromodulation Surgeries (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 Table 13: Neurorrhaphy (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2018-2025 Table 14: Neurorrhaphy (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 Table 15: Neurorrhaphy (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025 Table 16: Nerve Grafting (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 17: Nerve Grafting (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 Table 18: Nerve Grafting (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 19: Stem Cell Therapy (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2through 2025 Table 20: Stem Cell Therapy (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 Table 21: Stem Cell Therapy (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 Table 22: Hospitals & Clinics (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 Table 23: Hospitals & Clinics (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 Table 24: Hospitals & Clinics (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 Table 25: Ambulatory Surgery Centers (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2018-2025 Table 26: Ambulatory Surgery Centers (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2009-2017 Table 27: Ambulatory Surgery Centers (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Table 28: United States Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 29: Nerve Repair and Regeneration Market in the United States by Product: A Historic Review in US$ Thousand for 2009-2017 Table 30: United States Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 31: United States Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 32: Nerve Repair and Regeneration Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017 Table 33: Nerve Repair and Regeneration Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 Table 34: United States Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 35: Nerve Repair and Regeneration Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2009-2017 Table 36: Nerve Repair and Regeneration Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025 CANADA Table 37: Canadian Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 38: Canadian Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 39: Nerve Repair and Regeneration Market in Canada: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 40: Canadian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 41: Nerve Repair and Regeneration Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 42: Canadian Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 43: Canadian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 44: Nerve Repair and Regeneration Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 45: Canadian Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 JAPAN Table 46: Japanese Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 47: Nerve Repair and Regeneration Market in Japan: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 48: Japanese Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 49: Japanese Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 50: Japanese Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 51: Nerve Repair and Regeneration Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 Table 52: Japanese Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 53: Japanese Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 54: Nerve Repair and Regeneration Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025 CHINA Table 55: Chinese Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 56: Nerve Repair and Regeneration Historic Market Analysis in China in US$ Thousand by Product: 2009-2017 Table 57: Chinese Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 58: Chinese Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 59: Nerve Repair and Regeneration Market Review in China in US$ Thousand by Application: 2009-2017 Table 60: Chinese Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 61: Chinese Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 62: Nerve Repair and Regeneration Market Review in China in US$ Thousand by End-Use: 2009-2017 Table 63: Chinese Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 EUROPE Table 64: European Nerve Repair and Regeneration Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 Table 65: Nerve Repair and Regeneration Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 Table 66: European Nerve Repair and Regeneration Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 Table 67: European Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 68: Nerve Repair and Regeneration Market in Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 69: European Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 70: European Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 71: Nerve Repair and Regeneration Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 72: European Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 73: European Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 74: Nerve Repair and Regeneration Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 75: European Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 FRANCE Table 76: Nerve Repair and Regeneration Market in France by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 77: French Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 78: French Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 79: Nerve Repair and Regeneration Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 Table 80: French Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 81: French Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 82: Nerve Repair and Regeneration Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2018-2025 Table 83: French Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 84: French Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 GERMANY Table 85: Nerve Repair and Regeneration Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 86: German Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 87: German Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 88: Nerve Repair and Regeneration Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 89: German Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 90: Nerve Repair and Regeneration Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 Table 91: Nerve Repair and Regeneration Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 92: German Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 93: Nerve Repair and Regeneration Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025 ITALY Table 94: Italian Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 95: Nerve Repair and Regeneration Historic Market Analysis in Italy in US$ Thousand by Product: 2009-2017 Table 96: Italian Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 97: Italian Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 98: Nerve Repair and Regeneration Market Review in Italy in US$ Thousand by Application: 2009-2017 Table 99: Italian Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 100: Italian Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 101: Nerve Repair and Regeneration Market Review in Italy in US$ Thousand by End-Use: 2009-2017 Table 102: Italian Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 UNITED KINGDOM Table 103: United Kingdom Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 104: Nerve Repair and Regeneration Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 105: United Kingdom Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 106: United Kingdom Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 107: United Kingdom Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 108: Nerve Repair and Regeneration Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 Table 109: United Kingdom Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2to 2025 Table 110: United Kingdom Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 111: Nerve Repair and Regeneration Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025 SPAIN Table 112: Spanish Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 113: Spanish Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 114: Nerve Repair and Regeneration Market in Spain: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 115: Spanish Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 116: Nerve Repair and Regeneration Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 117: Spanish Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 118: Spanish Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 119: Nerve Repair and Regeneration Market in Spain: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 120: Spanish Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 RUSSIA Table 121: Russian Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 122: Nerve Repair and Regeneration Market in Russia by Product: A Historic Review in US$ Thousand for 2009-2017 Table 123: Russian Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 124: Russian Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 125: Nerve Repair and Regeneration Historic Demand Patterns in Russia by Application in US$ Thousand for 2009-2017 Table 126: Nerve Repair and Regeneration Market Share Breakdown in Russia by Application: 2009 VS 2019 VS 2025 Table 127: Russian Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 128: Nerve Repair and Regeneration Historic Demand Patterns in Russia by End-Use in US$ Thousand for 2009-2017 Table 129: Nerve Repair and Regeneration Market Share Breakdown in Russia by End-Use: 2009 VS 2019 VS 2025 REST OF EUROPE Table 130: Rest of Europe Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 131: Nerve Repair and Regeneration Market in Rest of Europe in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 132: Rest of Europe Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 133: Rest of Europe Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 134: Nerve Repair and Regeneration Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 135: Rest of Europe Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 136: Rest of Europe Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 137: Nerve Repair and Regeneration Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 138: Rest of Europe Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 ASIA-PACIFIC Table 139: Asia-Pacific Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 140: Nerve Repair and Regeneration Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017 Table 141: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025 Table 142: Nerve Repair and Regeneration Market in Asia-Pacific by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 143: Asia-Pacific Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 144: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 145: Nerve Repair and Regeneration Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 Table 146: Asia-Pacific Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 147: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 148: Nerve Repair and Regeneration Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2018-2025 Table 149: Asia-Pacific Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 150: Asia-Pacific Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 AUSTRALIA Table 151: Nerve Repair and Regeneration Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 152: Australian Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 153: Australian Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 154: Nerve Repair and Regeneration Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 155: Australian Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 156: Nerve Repair and Regeneration Market Share Distribution in Australia by Application: 2009 VS 2019 VS 2025 Table 157: Nerve Repair and Regeneration Market in Australia: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 158: Australian Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 159: Nerve Repair and Regeneration Market Share Distribution in Australia by End-Use: 2009 VS 2019 VS 2025 INDIA Table 160: Indian Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 161: Indian Nerve Repair and Regeneration Historic Market Review by Product in US$ Thousand: 2009-2017 Table 162: Nerve Repair and Regeneration Market in India: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 163: Indian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 164: Nerve Repair and Regeneration Market in India: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 165: Indian Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 166: Indian Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 167: Nerve Repair and Regeneration Market in India: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 168: Indian Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 SOUTH KOREA Table 169: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 170: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 171: Nerve Repair and Regeneration Market Share Distribution in South Korea by Product: 2009 VS 2019 VS 2025 Table 172: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2018-2025 Table 173: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Application: 2009-2017 Table 174: Nerve Repair and Regeneration Market Share Distribution in South Korea by Application: 2009 VS 2019 VS 2025 Table 175: Nerve Repair and Regeneration Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025 Table 176: South Korean Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by End-Use: 2009-2017 Table 177: Nerve Repair and Regeneration Market Share Distribution in South Korea by End-Use: 2009 VS 2019 VS 2025 REST OF ASIA-PACIFIC Table 178: Rest of Asia-Pacific Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 179: Nerve Repair and Regeneration Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 180: Rest of Asia-Pacific Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 181: Rest of Asia-Pacific Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 182: Rest of Asia-Pacific Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 183: Nerve Repair and Regeneration Market Share Shift in Rest of Asia-Pacific by Application: 2009 VS 2019 VS 2025 Table 184: Rest of Asia-Pacific Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 185: Rest of Asia-Pacific Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 186: Nerve Repair and Regeneration Market Share Shift in Rest of Asia-Pacific by End-Use: 2009 VS 2019 VS 2025 LATIN AMERICA Table 187: Latin American Nerve Repair and Regeneration Market Trends by Region/Country in US$ Thousand: 2018-2025 Table 188: Nerve Repair and Regeneration Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017 Table 189: Latin American Nerve Repair and Regeneration Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025 Table 190: Latin American Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 191: Nerve Repair and Regeneration Historic Market Analysis in Latin America in US$ Thousand by Product: 2009-2017 Table 192: Latin American Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 193: Latin American Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 194: Nerve Repair and Regeneration Market Review in Latin America in US$ Thousand by Application: 2009-2017 Table 195: Latin American Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 196: Latin American Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 197: Nerve Repair and Regeneration Market Review in Latin America in US$ Thousand by End-Use: 2009-2017 Table 198: Latin American Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 ARGENTINA Table 199: Argentinean Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 200: Nerve Repair and Regeneration Market in Argentina in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 201: Argentinean Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 202: Argentinean Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 203: Nerve Repair and Regeneration Market in Argentina: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 204: Argentinean Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 205: Argentinean Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 206: Nerve Repair and Regeneration Market in Argentina: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 207: Argentinean Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 BRAZIL Table 208: Nerve Repair and Regeneration Market in Brazil by Product: Estimates and Projections in US$ Thousand for the Period 2018-2025 Table 209: Brazilian Nerve Repair and Regeneration Historic Market Scenario in US$ Thousand by Product: 2009-2017 Table 210: Brazilian Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 211: Nerve Repair and Regeneration Quantitative Demand Analysis in Brazil in US$ Thousand by Application: 2018-2025 Table 212: Brazilian Nerve Repair and Regeneration Historic Market Review in US$ Thousand by Application: 2009-2017 Table 213: Brazilian Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 Table 214: Nerve Repair and Regeneration Quantitative Demand Analysis in Brazil in US$ Thousand by End-Use: 2018-2025 Table 215: Brazilian Nerve Repair and Regeneration Historic Market Review in US$ Thousand by End-Use: 2009-2017 Table 216: Brazilian Nerve Repair and Regeneration Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025 MEXICO Table 217: Nerve Repair and Regeneration Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 218: Mexican Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 219: Mexican Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 220: Nerve Repair and Regeneration Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 221: Mexican Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 222: Nerve Repair and Regeneration Market Share Distribution in Mexico by Application: 2009 VS 2019 VS 2025 Table 223: Nerve Repair and Regeneration Market in Mexico: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 224: Mexican Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 225: Nerve Repair and Regeneration Market Share Distribution in Mexico by End-Use: 2009 VS 2019 VS 2025 REST OF LATIN AMERICA Table 226: Rest of Latin America Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 227: Nerve Repair and Regeneration Market in Rest of Latin America by Product: A Historic Review in US$ Thousand for 2009-2017 Table 228: Rest of Latin America Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 229: Rest of Latin America Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 230: Nerve Repair and Regeneration Historic Demand Patterns in Rest of Latin America by Application in US$ Thousand for 2009-2017 Table 231: Nerve Repair and Regeneration Market Share Breakdown in Rest of Latin America by Application: 2009 VS 2019 VS 2025 Table 232: Rest of Latin America Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 233: Nerve Repair and Regeneration Historic Demand Patterns in Rest of Latin America by End-Use in US$ Thousand for 2009-2017 Table 234: Nerve Repair and Regeneration Market Share Breakdown in Rest of Latin America by End-Use: 2009 VS 2019 VS 2025 MIDDLE EAST Table 235: The Middle East Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 Table 236: Nerve Repair and Regeneration Market in the Middle East by Region/Country in US$ Thousand: 2009-2017 Table 237: The Middle East Nerve Repair and Regeneration Market Share Breakdown by Region/Country: 2009, 2019, and 2025 Table 238: The Middle East Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018 to 2025 Table 239: The Middle East Nerve Repair and Regeneration Historic Market by Product in US$ Thousand: 2009-2017 Table 240: Nerve Repair and Regeneration Market in the Middle East: Percentage Share Breakdown of Sales by Product for 2009, 2019, and 2025 Table 241: The Middle East Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 Table 242: Nerve Repair and Regeneration Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 Table 243: The Middle East Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 244: The Middle East Nerve Repair and Regeneration Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2to 2025 Table 245: Nerve Repair and Regeneration Market in the Middle East: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2009-2017 Table 246: The Middle East Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 IRAN Table 247: Iranian Market for Nerve Repair and Regeneration: Annual Sales Estimates and Projections in US$ Thousand by Product for the Period 2018-2025 Table 248: Nerve Repair and Regeneration Market in Iran: Historic Sales Analysis in US$ Thousand by Product for the Period 2009-2017 Table 249: Iranian Nerve Repair and Regeneration Market Share Analysis by Product: 2009 VS 2019 VS 2025 Table 250: Iranian Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 251: Iranian Nerve Repair and Regeneration Market in US$ Thousand by Application: 2009-2017 Table 252: Nerve Repair and Regeneration Market Share Shift in Iran by Application: 2009 VS 2019 VS 2025 Table 253: Iranian Demand Estimates and Forecasts for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 254: Iranian Nerve Repair and Regeneration Market in US$ Thousand by End-Use: 2009-2017 Table 255: Nerve Repair and Regeneration Market Share Shift in Iran by End-Use: 2009 VS 2019 VS 2025 ISRAEL Table 256: Israeli Nerve Repair and Regeneration Market Estimates and Forecasts in US$ Thousand by Product: 2018-2025 Table 257: Nerve Repair and Regeneration Market in Israel in US$ Thousand by Product: A Historic Review for the Period 2009-2017 Table 258: Israeli Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 259: Israeli Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 Table 260: Nerve Repair and Regeneration Market in Israel: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 Table 261: Israeli Nerve Repair and Regeneration Market Share Analysis by Application: 2009 VS 2019 VS 2025 Table 262: Israeli Nerve Repair and Regeneration Addressable Market Opportunity in US$ Thousand by End-Use: 2018-2025 Table 263: Nerve Repair and Regeneration Market in Israel: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2009-2017 Table 264: Israeli Nerve Repair and Regeneration Market Share Analysis by End-Use: 2009 VS 2019 VS 2025 SAUDI ARABIA Table 265: Saudi Arabian Nerve Repair and Regeneration Market Growth Prospects in US$ Thousand by Product for the Period 2018-2025 Table 266: Nerve Repair and Regeneration Historic Market Analysis in Saudi Arabia in US$ Thousand by Product: 2009-2017 Table 267: Saudi Arabian Nerve Repair and Regeneration Market by Product: Percentage Breakdown of Sales for 2009, 2019, and 2025 Table 268: Saudi Arabian Demand for Nerve Repair and Regeneration in US$ Thousand by Application: 2018 to 2025 Table 269: Nerve Repair and Regeneration Market Review in Saudi Arabia in US$ Thousand by Application: 2009-2017 Table 270: Saudi Arabian Nerve Repair and Regeneration Market Share Breakdown by Application: 2009 VS 2019 VS 2025 Table 271: Saudi Arabian Demand for Nerve Repair and Regeneration in US$ Thousand by End-Use: 2018 to 2025 Table 272: Nerve Repair and Regeneration Market Review in Saudi Arabia in US$ Thousand by End-Use: 2009-2017 Table 273: Saudi Arabian Nerve Repair and Regeneration Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025 UNITED ARAB EMIRATES Table 274: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 275: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 276: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by Product: 2009 VS 2VS 2025 Table 277: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Application for the Period 2018-2025 Table 278: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Application: 2009-2017 Table 279: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by Application: 2009 VS 2019 VS 2025 Table 280: Nerve Repair and Regeneration Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by End-Use for the Period 2018-2025 Table 281: United Arab Emirates Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by End-Use: 2009-2017 Table 282: Nerve Repair and Regeneration Market Share Distribution in United Arab Emirates by End-Use: 2009 VS 2VS 2025 REST OF MIDDLE EAST Table 283: Nerve Repair and Regeneration Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Product for the Period 2018-2025 Table 284: Rest of Middle East Nerve Repair and Regeneration Historic Market Analysis in US$ Thousand by Product: 2009-2017 Table 285: Rest of Middle East Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 286: Nerve Repair and Regeneration Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 Table 287: Rest of Middle East Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by Application: 2009-2017 Table 288: Nerve Repair and Regeneration Market Share Distribution in Rest of Middle East by Application: 2009 VS 2019 VS 2025 Table 289: Nerve Repair and Regeneration Market in Rest of Middle East: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2018-2025 Table 290: Rest of Middle East Nerve Repair and Regeneration Market in Retrospect in US$ Thousand by End-Use: 2009-2017 Table 291: Nerve Repair and Regeneration Market Share Distribution in Rest of Middle East by End-Use: 2009 VS 2019 VS 2025 AFRICA Table 292: African Nerve Repair and Regeneration Market Estimates and Projections in US$ Thousand by Product: 2018 to 2025 Table 293: Nerve Repair and Regeneration Market in Africa by Product: A Historic Review in US$ Thousand for 2009-2017 Table 294: African Nerve Repair and Regeneration Market Share Breakdown by Product: 2009 VS 2019 VS 2025 Table 295: African Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 Table 296: Nerve Repair and Regeneration Historic Demand Patterns in Africa by Application in US$ Thousand for 2009-2017 Table 297: Nerve Repair and Regeneration Market Share Breakdown in Africa by Application: 2009 VS 2019 VS 2025 Table 298: African Nerve Repair and Regeneration Latent Demand Forecasts in US$ Thousand by End-Use: 2018 to 2025 Table 299: Nerve Repair and Regeneration Historic Demand Patterns in Africa by End-Use in US$ Thousand for 2009-2017 Table 300: Nerve Repair and Regeneration Market Share Breakdown in Africa by End-Use: 2009 VS 2019 VS 2025

IV. COMPETITION

Total Companies Profiled:

Read the full report: https://www.reportlinker.com/p05799212/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Excerpt from:
Global Nerve Repair and Regeneration Industry - GlobeNewswire

Read More...

Accurate Diagnostic Laboratories and Rutgers University Cell & DNA Repository Lab Work Together to Change the COVID-19 Testing Landscape – WFMZ…

Monday, April 6th, 2020

SOUTH PLAINFIELD, N.J., April 6, 2020 /PRNewswire/ -- Accurate Diagnostic Laboratories (ADL) and Rutgers University Cell & DNA Repository (RUCDR), through its Clinical Genomics Laboratory, are pleased to announce a joint mission aligning their efforts around improving testing capacity and service for the hospital inpatient population, health care providers and workers, first responders and patients.The relationship will facilitate providing high through-put and industry-leading turn around time for COVID-19 testing, also capitalizing on new methods to test. ADL and RUCDR have a long-standing relationship, where ADL performs diagnostic testing for RUCDR clinical trials, which aides in their data repository management. RUCDR, in conjunction with ADL's clinical client-base, fast-tracked the validation and verification of new testing methodologies, including saliva, for SARS-CoV-2 COVID-19. These alternate collection options will catapult the access of testing and screening to our most needed population."ADL's laboratory diagnostic capabilities, steeped in a tradition of offering the latest diagnostic technology offerings, is proud to expand our relationship with a local, world-renowned institution in Rutgers University Cell & DNA Repository laboratory.We want to do our mutual part to address the need for improved COVID-19 testing access, particularly for our front-line health care workers, hospital inpatient population, and first responders, by utilizing new collection and testing methods," says ADL's CEO, Rupen Patel.This is a game-changer for the market as "saliva testing will help with the global shortage of swabs for sampling and increase testing of patients, as it will not require health care professionals to collect samples," said Dr. Andrew Brooks, COO and director of technology development at RUCDR Infinite Biologics.He is also a professor in the Department of Genetics at Rutgers University-New Brunswick.As far as we know, we are the first and only laboratory to perform a significant validation and verification on multiple specimen types and not rely solely on the use of contrived samples.Accurate Diagnostic would like to formally thank those health care providers and health systems that assisted in the process to get this testing off the ground.

About Accurate Diagnostic Labs: Accurate Diagnostic Labs is one of the largest privately held, boutique, full-service clinical laboratories in the country.ADL, as a full-service core laboratory, proudly works with various entities on laboratory testing for clinical trial drug development and data repository in various market footprints to progress the field of disease state management and personalized medicine. With our local headquarters based in Central New Jersey, we pride ourselves in working with various healthcare corporations, institutions, health systems, and the local providers in the metropolitan area with the common goal of improving local and national healthcare.

Contact Information for ADL: For more information on ADL, please call at 732-839-3300 or visit online at http://www.accuratediagnosticlabs.com.

About RUCDR:RUCDR Infinite Biologics, which is part of Rutgers'Human Genetics Institute of New Jersey, is the world's largest university-based cell and DNA repository. Its mission is to understand the genetic causes of common, complex diseases and to discover diagnoses, treatments and cures for them. The organization collaborates with researchers in the public and private sectors throughout the world, providing the highest quality bio-banking services and biomaterials, as well as scientific and technical support.

Related Files

RUCDR ADL press release.docx

Related Images

rucdr.pngRUCDR

adl.pngADL

More:
Accurate Diagnostic Laboratories and Rutgers University Cell & DNA Repository Lab Work Together to Change the COVID-19 Testing Landscape - WFMZ...

Read More...

Is there a better market to invest in than healthcare? – MedCity News

Monday, April 6th, 2020

Recently, as I was scheduling a routine procedure, the nurse asked for my fax number so she could send me the pre-op procedures. A fax machine in todays age? I was flabbergasted, as this was from an affiliate of one of the most sophisticated medical institutions in the United States, if not the world. I asked her to send me an email, and she indicated her systems were not equipped to do that but she might be able to scan the instructions and email them to me.

In light of the sweeping spread of Covid-19 and the increased pressure that has been and will continue to be brought to bear on the healthcare system, my experience becomes almost chilling.

As Cynthia Cox, director of the Peterson-Kaiser Health System Tracker recently commented to Vox: The coronavirus outbreak is already exposing inefficiencies and inequities in our health system, and it is likely to put much more strain on the system in the coming weeks.

And yet, we shouldnt need a pandemic to inform us that we need to bring our healthcare administration practices into modernity or to show investors the opportunity they have to bring about much-needed change.

My fax experience indicates that one major area to address is the antiquity of our healthcare system. In a time when our leaders and healthcare providers now face real concerns about Covid-19s potential to overwhelm our facilities and drain our resources, we have to wonder could the application of modern technology have improved our ability to handle a pandemic? The answer seems surely to be yes.

It is mind-boggling how healthcare practices stand in stark contrast to how advances in technology and science have dramatically improved diagnosing and treating a host of issues. In this context, profiting as an investor doesnt require one to be steeped in science or healthcare. In fact, one might argue that its best to come from the outside and apply a fresh perspective, as has been the case with many recent healthcare-focused entrepreneurs.

The marketplace for healthcare is massive; it literally applies to everyone. In the US alone, healthcare represents over $3 trillion or 18% of GDP. Its perplexing how an industry so large and all-consuming could be forced to rely on something as outdated as the fax machine.

The size, growth and dysfunction in healthcare lead me to believe there are few investment environments as fruitful as those concentrating on improving many key aspects of healthcare. There are enormous opportunities in biotechnology that are now possible due to massive leaps in computing power and cost, but I believe there are also equal opportunities to improve the actual processes associated with delivering healthcare. In the latter category, one is not required to have a deep science or medical aptitude to pursue or capitalize on.

It is these areas that I am most excited about, as they present the possibilities of applying otherwise-available technology to improving quality and reducing costs. According to Harry Glorikian in Moneyball Medicine, There are also substantial wastes and inefficiencies in healthcare factors that could be costing the United States $1 trillion. This includes costs related to overtreatment and unnecessary treatments, bloated administrative structures, fraud and overspending that result from an inability to effectively shop for best price. These gaps, failings and their corresponding enormities are an entrepreneurs and investors dream.

At its core, medicine is about gathering, deciphering and sharing information; information flows between patients and doctors, doctors and doctors, doctors and pharmacists, and so forth. This stream of facts, figures, and experiences ultimately results in the care of a patient.

Thanks to the transformative technologies weve seen in this young century, a transformation in the processing and dissemination of information has taken place, with more knowledge at our fingertips than imaginable just a few decades ago. From globe-spanning social connections to seemingly infinite encyclopedias to mobile connectivity and computing, several quantum leaps forward in technological capabilities now enable forward-thinkers to create a new world where price transparency and seamless collaboration are the norm.

Yet, despite the enormous advances in processing power and capability over the last 50 to 100 years, there remain many aspects of the actual process of practicing medicine that have barely evolved. While machines are unlikely to completely replace doctors anytime soon (or ever), the fact remains that there are a number of areas where the accurate, timely processing of information can dramatically improve patient well-being and ultimately the quality, cost and accessibility of both basic and complex healthcare.

Areas, like streamlining administrative processes, reducing redundancy or unnecessary procedures, or facilitating early and frequent interaction with medical professionals to treat conditions early or prevent them in the first place, are ripe for disruption from innovative approaches driven by technology. Investments in the following four categories are among the most obvious, lucrative and mutually advantageous areas where transformational change is possible and needed.

Medical Records: When you think about it, health records are actually incredibly inefficient. Not only do you have to fill out comprehensive medical questionnaires by handyou have to repeat this process every time you change doctors, switch insurance companies, or alter your records in any way. Not only is this a colossal waste of time, but I shudder to think of the details that are mistaken or forgotten and how that might impact optimal care.

Its not unreasonable to expect that, in todays digital age, ones health records should not only be easily accessible but also reside with the individual rather than being dispersed among the countless healthcare providers that the person is involved with. For too long, healthcare providers have been overly protective of this information often to the detriment of the patient. While some strides have been made in this area, substantial work remains to be done to create true interoperability among providers for a specific patient.

This efficiency will improve the process of caring for a patient and in many cases will improve outcomes because doctors will always instantly have comprehensive information at their fingertips. Medical histories, treatment plans or idiosyncratic issues will no longer slip through the cracks. The scope of this issue is highlighted when considering patients dealing with multiple complex issues that might involve numerous specialists and general practitioners. Moreover, a patients health record shouldnt be just for the provider, it should be user-friendly so that the patients themselves can monitor and manage their health.

Big players in tech are already making strides towards filling this customer service void, but the big gamechanger in this field still has yet to present itself. Its a completely realistic expectation that within the next decade well have moved onto quick, convenient, and secure medical records. There likely will be many players enabling the gathering, managing and sharing of patient information; however, the real transformational change will occur when the data contained in the health record is used to proactively diagnose and treat patients.

The Delivery of Care: Traditionally, the doctors office or hospitals was where medicine was almost exclusively practiced. Today, technology is enabling care for many basic issues to be delivered remotely to wherever the patient is. Telemedicine, or virtual care, utilizes technology so that doctors can seamlessly and, in some cases, instantly connect with patients to deliver care on demand.

The first iteration of this approach is traditional telemedicine, which uses video conferencing or a phone call to connect a doctor and patient. This approach is quickly and not unsurprisingly being usurped by asynchronous text on a smartphone how the world prefers to communicate where the doctors capabilities are being augmented by deep technology and AI. Providing easy and true on-demand accessibility for patients enables them to be treated early and often, which will unquestionably improve health outcomes. Pairing physicians with leading-edge technology can generate substantial efficiencies and leverage that, in turn, will reduce costs, increase quality and substantially expand those covered.

The flu offers a simple illustration of the power of technology that allows on-demand, remote care delivery: At the onset of symptoms, a patient can engage with a doctor and receive treatment. Instead of juggling their schedules or waiting to see a doctor which averages 29 days according to a Merritt Hawkins 2017 study the disease is treated promptly before it gets too far along. Furthermore, this remote treatment dramatically reduces contamination because there is no sitting in a waiting room or traveling often on mass transit to visit a doctor or urgent care center. In this scenario, everyone patient, provider, community and employer wins.

Similarly, technology is transforming how a patient is monitored either following a procedure or for chronic issues. In many cases, vital statistics can be monitored remotely and transmitted instantly to a care team. This enables patients to recover at home, which is more comfortable, cheaper, and comes without the infectious risks present at a hospital. For patients with chronic diseases, the ability to easily and accurately monitor factors like blood glucose levels, heart rate or blood pressure can be transformative in terms of managing a disease or preventing problems down the road. On a related note, technology-based tools can be employed to aid and ensure prescription adherence, which currently poses a huge and unnecessary cost to the system.

Healthcare delivery is only beginning to embrace the power of technology especially that of a smartphone to cut costs, increase access and improve quality. As I previously wrote, I believe that the power and ubiquity of smartphones will improve the worlds health on an individual and collective basis. Virtually every other aspect of our lives have been enhanced by this technology with the exception of primary healthcare.

Clinical Decision Support: The capabilities of AI, machine learning and big data can be applied to many aspects of healthcare in order to leverage a doctors time, improve quality and drive much needed efficiencies. Deep technology can now review images and tests faster and often more accurately than humans. The sheer mass and dispersion of medical information and current research makes it virtually impossible for a single doctor to always be up to speed. Technology that can foster the analysis and sharing of vast and complicated information will give doctors instant access to the plethora of research studies and clinical trials that might be relevant to their patients. Using technology to quickly and accurately identify and process information on a clients behalf will only improve care and drive down costs.

Precision Medicine / Personalized Diagnoses: Given the powerful computers at our disposal, it is easy to envision how we could use computers to aid decision-making, plugging in numerous permutations, conditions, and individual attributes unique to patients in order to determine the problems at hand and the optimal treatment plan. For example, for a prescription one will no longer need to rely on the catch all adult dosage and can instead determine the best amount for each patient based on their unique composition and metabolism.

Personalizing diagnoses is where AI is beginning to show real promise. Researchers have developed the technology for identifying heart disease, lung cancer and eye maladies with machine learning, and theyre only getting started. Even more cutting-edge is where a patients genome is analyzed to determine precisely the diagnosis and corresponding treatment plan. This capability is still in its infancy and only possible due to the advancements and price reductions in computing power.

Healthcare is ripe for the benefits technology affords and, as the responses and capabilities relating to Covid-19 demonstrates, desperately needs an update. Relative to other areas, I think the aforementioned categories might be low hanging fruit and hence represent significant investment potential. What I find particularly exciting is that the space is so large and in such desperate need that there will be a wide array of places to invest with potentially several players in each area. Fields such as Artificial Intelligence, Data Management and Cloud Computing offer much promise when applied to healthcare, especially in disrupting several areas that suffer from stagnation and lack of development. These applications will benefit doctors and patients alike while concurrently offering very attractive returns to the investors and entrepreneurs behind the companies. Lastly, and equally compelling, is that an investment that helps improve healthcare provides a greater good by enhancing lives and benefiting communities.

Photo: JamesBrey, Getty Images

Go here to see the original:
Is there a better market to invest in than healthcare? - MedCity News

Read More...

Global Minimally Invasive Biopsy Technologies Markets, 2019-2030 – A $4+ Billion Opportunity with Focus on Liquid Biopsy, Optical Biopsy, and Brush…

Monday, April 6th, 2020

DUBLIN, April 6, 2020 /PRNewswire/ -- The "Global Minimally Invasive Biopsy Technologies Market: Focus on Liquid Biopsy, Optical Biopsy, and Brush Biopsy, Pigmented Lesion Assays, and Breath Biopsy, Regulatory Scenario, Therapeutic Application, Competitive Landscape,18 Countries' Data - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering.

According to the report, the global minimally invasive biopsy technologies market was valued at $924.8 million in 2018 and is anticipated to reach $4.03 billion by 2030. The global minimally invasive biopsy technologies market is expected to grow at a double-digit compound annual growth rate (CAGR) in the forecast period 2019-2030, aided primarily by the anticipated launch of novel minimally invasive biopsy technologies.

The rapidly growing incidences of cancer and other chronic inflammatory disorders are inciting the use of minimally invasive and real-time diagnostic methods for early detection. With better patient compliance and greater sensitivity, minimally invasive biopsy technologies such as liquid biopsy and optical biopsy are emerging as novel tools for the early detection and effective disease management. Additionally, several other technologies including brush biopsy, fine needle aspiration, breath biopsy, and pigmented lesion assays are considerably evolving to be used in the minimally invasive management of cancer.

The increasing adoption of targeted therapies and the growing prominence of the concept of personalized medicine is driving the adoption of minimally invasive biopsy technologies. The increasing adoption is further expected to bring down the cost and is expected to improve the patient access to these technologies.

North America is the leading contributor in the global minimally invasive biopsy technologies market and contributed approximately 62.06% to the global market value in 2018. This region is anticipated to grow at a CAGR of 11.25% during the forecast period 2019-2030 and to continue dominating the global market in 2030 as well. However, the European region is expected to grow at an impressive CAGR of 15.40% during the forecast period 2019-2030. The Asia-Pacific region contributed a share of 12.41% to the global market and is anticipated to grow at a CAGR of 14.65% during the forecast period 2019-2030.

Research Highlights

Optical biopsy expected to witness an impressive CAGR of 15.77% during the forecast period 2019-2030. Moreover, in terms of therapeutic application, prostate cancer is expected to witness an impressive growth at a CAGR of 14.97% during the forecast period 2019-2030.

Liquid biopsy is currently the largest shareholder in the global minimally invasive biopsy technologies market. This market dominance is largely attributed to the worldwide availability of a significant number of liquid biopsy technologies.

This market intelligence report provides a multi-dimensional view of the global minimally invasive biopsy technologies market in terms of market size and growth potential. This research report aims at answering various aspects of the global minimally invasive biopsy technologies market with the help of key factors driving the market, restraints that can possibly inhibit the overall growth of the market, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as product launches and approvals, partnerships, collaborations, business expansions, as well as mergers and acquisitions. The research report provides a comprehensive analysis of the product sales, manufacturers, service providers, and trend analysis by segment, and growth share analysis by region. Additionally, the report provides a comprehensive attractive analysis and opportunity analysis for the entire global minimally invasive biopsy technologies market for 2018 and 2030.

This report is a meticulous compilation of the research of about 65 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of 9 leading companies, market participants, and vendors. The report also comprises 15 detailed company profiles including that of Abcodia Ltd., Adaptive Biotechnologies, Biocept, Inc., Caliber Imaging & Diagnostics, Chronix Biomedical, DermTech, F. Hoffmann-La Roche Ltd, Guardant Health, Inc., Mauna Kea Technologies, Myriad Genetics, NeoGenomics Laboratories, Inc., Owlstone Medical Ltd, QIAGEN, Thermo Fisher Scientific, and Veracyte, Inc.

The answers to the following key questions can be derived from this report:

Key Topics Covered

Executive Summary

1 Product Definition1.1 Inclusions and Exclusions

2 Research Scope2.1 Scope of Work2.2 Key Questions Answered in the Report

3 Research Methodology3.1 Global Minimally Invasive Biopsy Technologies Market: Research Methodology3.1.1 Primary Data Sources3.1.2 Secondary Data Sources3.1.3 Selection Criteria for Company Profiles

4 Industry Analysis4.1 Industry Ecosystem4.2 Regulatory Framework and Government Initiatives4.2.1 Liquid Biopsy: Regulatory Framework4.2.1.1 Liquid Biopsy: Regulations in the U.S.4.2.1.2 Liquid Biopsy: Regulations in Other Countries4.2.2 Optical Biopsy and Other Technologies: Regulatory Framework4.2.2.1 Optical Biopsy and Other Technologies: Regulations in the U.S.4.2.2.2 Optical Biopsy and Other Technologies: Regulations in Europe4.2.2.3 Optical Biopsy and Other Technologies: Regulations in Other Countries4.3 Patent Analysis4.3.1 Liquid Biopsy: Patent Analysis4.3.2 Optical Biopsy: Patent Analysis4.4 Physician's Perception

5 Competitive Landscape5.1 Key strategies and Developments5.1.1 Partnerships, Alliances, and Business Expansions5.1.2 New Offerings5.1.3 Funding Activities5.1.4 Procurement and Sales Agreements5.1.5 Regulatory and Legal Developments5.1.6 Mergers and Acquisitions5.2 Market Share Analysis5.2.1 Market Share Analysis: Global Liquid Biopsy Market5.2.2 Market Share Analysis: Global Optical Biopsy Market5.2.3 Market Share Analysis: Global Other Technologies Market5.3 Growth Share Analysis5.3.1 Growth Share Matrix (by Technology)5.3.2 Growth Share Matrix (by Therapeutic Application)5.3.3 Growth Share Matrix (by Region)

6 Global Minimally Invasive Biopsy Technologies Market, 2018-20306.1 Assumptions and Limitations6.2 Key Findings and Opportunity Assessment6.3 Global Minimally Invasive Biopsy Technologies, Market Scenario6.3.1 Global Minimally Invasive Biopsy Technologies Market Size and Forecast (2018-2030)6.3.2 Market Dynamics6.3.2.1 Overview6.3.2.2 Impact Analysis6.3.2.3 Market Drivers6.3.2.3.1 Rising Global Burden of Cancer6.3.2.3.2 Increasing Number of Cross-Industry Collaborations6.3.2.3.3 Growing Prominence of Precision Medicine6.3.2.4 Market Restraints6.3.2.4.1 Uncertain Regulatory Requirements6.3.2.4.2 Lack of Favorable Reimbursement Policies6.3.2.4.3 Technical Challenges Associated with the Analysis of Circulating Biomarkers6.3.2.5 Market Opportunities6.3.2.5.1 Business Expansion in Emerging Economies6.3.2.5.2 Integration of Artificial Intelligence (AI)6.3.2.5.3 Rising Number of Initiatives by the Government6.4 Market Estimation Method

7 Global Minimally Invasive Biopsy Technologies Market, by Technology, 2018-20307.1 Overview7.2 Global Liquid Biopsy Market Scenario, 2018-20307.2.1 Principle and Advantages of Liquid Biopsy7.2.2 Key Findings and Opportunity Assessment7.2.3 Global Liquid Biopsy Market, Market Size and Forecast (2018-2030)7.2.3.1 Market Dynamics7.2.3.1.1 Impact Analysis7.2.3.1.2 Market Drivers7.2.3.1.2.1 Increasing Demand for Liquid Biopsy Tests7.2.3.1.2.2 Recent Product Launches and Approvals7.2.3.1.2.3 Strong Pipeline7.2.3.1.3 Market Restraints7.2.3.1.3.1 Uncertain Regulatory Requirements7.2.3.1.3.2 Lack of Adequate Reimbursement7.2.4 Global Liquid Biopsy Market Segmentation7.2.4.1 Global Liquid Biopsy Market (by Product), 2018-20307.2.4.1.1 Overview7.2.4.1.2 Tests7.2.4.1.3 Kits and Consumables7.2.4.1.4 Instruments7.2.4.2 Global Liquid Biopsy Market, by Circulating Biomarker, Market Size and Forecast (2018-2030)7.2.4.2.1 Overview7.2.4.2.2 Circulating Tumor DNA (ctDNA)7.2.4.2.3 Circulating Tumor Cells (CTCs)7.2.4.2.4 Cell-Free DNA (cfDNA)7.2.4.2.5 Extracellular Vesicles and Others7.2.4.3 Global Liquid Biopsy Market, by Clinical Application, Market Size and Forecast (2018-2030)7.2.4.3.1 Overview7.2.4.3.2 Treatment Monitoring7.2.4.3.3 Prognosis and Recurrence Monitoring7.2.4.3.4 Treatment Selection7.2.4.3.5 Diagnosis and Screening7.2.4.4 Global Liquid Biopsy Market, by Therapeutic Application, Market Size and Forecast (2018-2030)7.2.4.4.1 Overview7.2.4.4.2 Lung Cancer7.2.4.4.3 Breast Cancer7.2.4.4.4 Prostate Cancer7.2.4.4.5 Colorectal Cancer7.2.4.4.6 Blood Cancer7.2.4.4.7 Other Types of Cancer7.2.4.4.8 Non-Oncology Applications7.3 Global Optical Biopsy Market Scenario, 2018-20307.3.1 Principle and Advantages of Optical Biopsy7.3.2 Key Findings and Opportunity Assessment7.3.3 Global Optical Biopsy Market, Market Size and Forecast (2018-2030)7.3.3.1 Market Dynamics7.3.3.1.1 Impact Analysis7.3.3.1.2 Market Drivers7.3.3.1.2.1 Recent Product Launches and Approvals7.3.3.1.2.2 Significant Number of Funding and Investments7.3.3.1.2.3 Anticipated Product Launches7.3.3.1.3 Market Restraints7.3.3.1.3.1 Lack of Favorable Reimbursement7.3.3.1.3.2 Stringent Regulatory Guidelines7.3.4 Global Optical Biopsy Market (by Therapeutic Application), 2018-20307.3.4.1 Overview7.3.4.2 Oncology7.3.4.3 Non-Oncology Applications7.4 Global Other Technologies Market Scenario, 2018-20307.4.1 Overview7.4.2 Key Findings and Opportunity Assessment7.4.3 Global Other Technologies Market, Market Size and Forecast (2018-2030)7.4.3.1 Market Dynamics7.4.3.1.1 Impact Analysis7.4.3.1.2 Market Drivers7.4.3.1.2.1 Ongoing Strategic Collaborations and M&A Activities7.4.3.1.2.2 Strong Product Pipeline7.4.3.1.3 Market Restraints7.4.3.1.3.1 Poor Reimbursement Scenario7.4.3.1.3.2 Limited Scope of Expansion in Emerging Economies7.4.4 Global Other Technologies Market, (by Therapeutic Application)7.4.4.1 Overview7.4.4.2 Lung Cancer7.4.4.3 Melanoma7.4.4.4 Thyroid Cancer7.4.4.5 Non-Oncology Applications

8 Global Minimally Invasive Biopsy Technologies Market, (by Region), 2018-20308.1 Overview and Key Findings8.2 North America8.3 Europe8.4 Asia-Pacific8.5 Latin America and the Middle East8.6 Rest-of-the-World

9 Company Profiles9.1 Abcodia Ltd.9.2 Adaptive Biotechnologies9.3 Biocept, Inc.9.4 Caliber Imaging & Diagnostics9.5 Chronix Biomedical9.6 DermTech9.7 F. Hoffmann-La Roche Ltd.9.8 Guardant Health, Inc.9.9 Mauna Kea Technologies9.10 Myriad Genetics9.11 NeoGenomics Laboratories, Inc.9.12 Owlstone Medical Ltd.9.13 QIAGEN9.14 Thermo Fisher Scientific9.15 Veracyte, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3128v2

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-minimally-invasive-biopsy-technologies-markets-2019-2030---a-4-billion-opportunity-with-focus-on-liquid-biopsy-optical-biopsy-and-brush-biopsy-pigmented-lesion-assays-and-breath-biopsy-301035982.html

SOURCE Research and Markets

Read more:
Global Minimally Invasive Biopsy Technologies Markets, 2019-2030 - A $4+ Billion Opportunity with Focus on Liquid Biopsy, Optical Biopsy, and Brush...

Read More...

3 High-Growth Trends to Invest In Now – Investorplace.com

Monday, April 6th, 2020

Heading into this year, I was passionate about getting a very important message in front of investors.

Source: Shutterstock

It was my thesis that the next decade would not only be the most innovative in history, but that the stock market would experience its largest gains ever.

The start of 2020 as brutal as it has been reminds me of 1990. Stocks had already been in a bull market for eight years when the ball dropped on 1989 and ushered in the new decade. Most experts believed the bull market was over and that the 1990s would be a lost decade.

Boy, were they wrong.

The 1990s went on to become one of the greatest decades for stocks. Little technology companies youd never heard of became household names. Dell Computer now Dell Technologies (NYSE:DELL) gained over 91,000% during the 1990s. The biggest gains of the decade were driven by a plethora of new technologies centered around the internet and personal computing.

Today, we are now three months into the 2020s and stocks are in a similar situation. We entered the decade on the back of a 10-year bull market, only to slide quickly into a bear market.

Most people dont realize this, but the Dow did something similar in 1990. It fell by 19.5% essentially a bear market to start the decade before powering higher. I believe we will look back at the current sell-off and see it as the last great buying opportunity before a booming decade.

The selling is creating buying opportunities in investment trends that wont slow due to the pandemic. In fact, they could even accelerate due to the changing global landscape. Lets take a look at a few

Robotics:According to the editorial board atScience Robotics, robots could be an alternative to humans when it comes to certain healthcare tasks. Especially during a pandemic. Robots could collect lab results, automate lab tests, and help disinfect the patient rooms. In China, it was deemed too dangerous for humans to make critical deliveries of medicine and food into infected areas, so the country turned to robots.

Genomics:The future of healthcare will be based on advances in both technology and medicine. The latter will rely on the field of genomics. In the coming decade, it will be the norm to have your genome sequenced. This information will help create personalized medicine for each patient, as well as help speed up the creation of new drugs.

The response to the coronavirus is a great example of how medicine is evolving. In 10 years, this type of pandemic would not be an issue. The combination of artificial intelligence (AI), quantum computing, and genomics would create a vaccine within days.

Tele-everything:The biggest change to our lives throughout this ordeal has been the self-isolation. Either through a government mandate or by choice, most people around the globe are staying inside and not going about their normal activities. This has led to a work-from-home, school-from-home, and even workout-from-home situation.

The companies behind this trend are here to stay. When the pandemic is over, people will go back to work, school, and their local fitness facilities. But the tele-everything trend is not going away. In some circumstances, it is more convenient than what we were accustomed to. Everything from software companies to one of my favorite stocks,Teladoc (NYSE:TDOC), to online education will be pushed to grow faster and quicker after the pandemic.

Even though a lot of the stocks in these trends have been beaten down in the last month, the trends themselves are not dead. Nothing I mean nothing in life goes straight up. When it comes to the stock market, the strongest trends will hit speed bumps but those bumps offer investors opportunities.

Let me be straight with you. If you want to be wealthy, you must buy into high-growth, long-term trends. And to make the BIG money you need to buy when everyone else is selling.

That day is today.

Matthew McCall left Wall Street to actually help investors by getting them into the worlds biggest, most revolutionary trends BEFORE anyone else. The power of being first gave Matts readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA) and +1,044% in Tesla (TSLA), just to name a few. Click here to see what Matt has up his sleeve now. Matt does not directly own the aforementioned securities.

More:
3 High-Growth Trends to Invest In Now - Investorplace.com

Read More...

COVID-19 transforms the challenges of Personalized Medicine for 2020 – Explica

Monday, April 6th, 2020

The current pandemic situation that the world is suffering due to the SARS-CoV-2 coronavirus is hopelessly transforming any forecast that would have been set for 2020 in most environments. Even more in the field of health, where efforts are being made to end this situation.

In the case of personalized medicine in Spain, this year they expected to solve technological, social, legal, ethical and healthcare challenges with the possible approval of a strategic plan by the Government, which has been analyzed by the Senate for more than two years with the collaboration of experts in the field. A long-awaited regulation that it is more than likely to delay again.

From the point of view of the investigation, advances were outlined in CRISPR / Cas9, a molecular tool to edit or correct the genome of a cell. Also in a more efficient and combined use of the so-called micas omics sciences: genomics, metabolomics, epigenomics, etc., which, even though they have been going for several years, are still at the dawn of their journey.

Companies like OncoDNA, a company specialized in precision medicine for the treatment and diagnosis of cancer, continue working to promote new advances in this last section. She has spent several years dedicated to carrying out genomic analysis of samples from cancer patients, tissue and blood (liquid biopsy), to offer more information on the genetic profile of each tumor to specialists and thus be able to determine the most appropriate therapy for the patient.

Over the past 12 months the number of genes analyzed has been expanded in their tests, arriving their OncoDEEP and OncoSTRAT & GO solid biopsy panels until 313 and even, combining tissue analysis with liquid biopsy in stage IV solid tumors. Incorporating new essential biomarkers to know the peculiarities that can occur in each patient.

Pending all the news

In the same way, researchers continue to be very aware of the different publications that are appearing in the most prestigious media in the world in the field of oncology to improve their services. An example of this were the changes adopted a few months ago in your OncoSTRAT & GO test.

This new version includes the study of germline mutations in the ATM, BRCA1 and BRCA2 genes, as well as other pathway genes involved in homologous recombination, which can also be treated with PARP inhibitors. A solution that is already available and that is especially useful in patients with ovarian, prostate, pancreas and triple negative breast cancer.

In laboratories, and with the collaboration of different hospitals and specialized cancer centers around the world, work is also being done on this combination of omics sciences, which could offer a much more individualized view of the molecular profile of each patient, thus improving their prospects of success against cancer. Even to turn them into an effective tool to predict and assume preventive intervention strategies.

More advances in big data

Processing large amounts of data it will also continue to be key in the field of personalized medicine. Increasingly, taking into account that the progressive evolution of the micas omics will require technologies that translate their results into a language understandable to healthcare professionals.

In the oncological case they begin to emerge computer applications capable of processing and translating in a very short time the large amount of genetic information that each genomic analysis offers us. As with OncoKDM, an intelligent online genomic interpretation platform that responds to the most immediate needs of oncologists, pathologists, and other specialists in molecular biology.

It is capable of bringing together all the information that has been collected about a patient, such as the results of any genomic technology, molecular pathology data or clinical information, analyzing and interpreting it effectively at a clinical and biological level in a few minutes. In this way, it facilitates the oncologists decision making when choosing the ideal therapy for the patient or searching for clinical trials available in their country of origin , explains Adriana Terrdez, director of OncoDNA in Spain and Portugal.

It is to be expected that solutions such as those of genomic tests or software and platforms for the processing and interpretation of genomic data continue to evolve in the future in order to improve cancer patient care and make the best decisions in each case. It is working day by day in order that the news arrive as soon as possible. Even in these uncertain times.

//

Visit link:
COVID-19 transforms the challenges of Personalized Medicine for 2020 - Explica

Read More...

Precision Medicine Market growth outlook with industry review and forecasts – GroundAlerts.com

Monday, April 6th, 2020

Technological advancements and scientific breakthroughs have propelled the assessment of pathogenesis and fostered precision medicine industry. Precision medicine has become instrumental in alleviating suffering pertaining to medical care, owing to unintended side effects resulting from one-size-fits-all approach.

Rapid transformation towards precision medicine is also believed to reduce the cost of treatment by doing away with inapt treatment plans. Precision medicine has become pivotal in leveraging doctors to select treatments based on a genetic understanding of the patient's disease and creating a personalized treatment plan.

Genetic laboratory industry is believed to be using processing power, data, science and operators to enhance the results for costly and debilitating diseases. In terms of technology, big data is touted to set the trend in precision medicine market as the technology enables more precision and tailoring compared to linking diverse data sets to showcase casual pathways. Dependence of precision medicine on big data has propelled the biomedical research.

Request sample copy of this report @ https://www.decresearch.com/request-sample/detail/671

Stakeholders have shown increased traction towards big data analytics for it complements clinical care and streamlines public health surveillance. Notably, big data has the ability to track and predict major outbreaks to boost public healthcare resources and disseminate healthcare message to patients using social media.

Profound deployment of sensing technologies has fared well for big data analytics. With soaring trend for implantable and wearing sensing has been in line with the increased bandwidth and improved microelectronics.

With the wealth of information to different disease, big data revolution has offered an opportunity to embrace AI and machine learning algorithms in the massive data set. Global Market Insights, Inc., predicts big data analytics market share to have been registered at 12% in 2019, citing influx of complex of data generating in healthcare sector.

Make Inquiry about this report @ https://www.decresearch.com/inquiry-before-buying/671

Recent advancements in technology indicate that stakeholders are increasingly using precision medicine in oncology. With neurological disorders being one of the leading causes of morbidity and disability globally, precision medicine has grown in significance. The disorder is expected to grow on the heels of increased life expectancy and population growth leading to economic burden and health issues.

Oncology has opened avenues for precision medicines as central nervous system (CNS) market share in 2019 was pegged at over 24%, mainly attributed to soaring prevalence of CNS disorders globally.

Use of precision medicine in healthcare IT companies will become more noticeable in the next five years owing to soaring demand for technologically advanced equipment for analysis, rapid integration and storage of patient data. In bid to push to the capabilities in data analysis, data acquisition, and analytics-based decision making, established technology players and startups are adopting precision medicine.

Several healthcare IT companies are offering operation and software tools for healthcare systems to adopt personalized medicine. Healthcare IT companies segment was pegged at around US$ 16 bn in 2019.

With the time ideal for disruption through strategic business model owing to changing healthcare dynamics, stakeholders are increasingly inclined towards infusing investment in MEA. Leading companies believe MEA to emerge as a prominent growth ground for the industry.

While massive data has been captured for advanced economies, dearth of data in African countries and most of the Gulf countries has signified the importance of precision medicine. Further, burgeoning population has also been one of the factors fueling growth in the region. MEA market was pegged at over USD 3.0 billion in 2019 and is estimated to expand at a CAGR of more than 10.0% during the forecast period.

View original post here:
Precision Medicine Market growth outlook with industry review and forecasts - GroundAlerts.com

Read More...

Insights On The Global Biochip Market To 2027 Featuring Abbott Laboratories, Agilent Technologies, PerkinElmer Inc., Fluidigm Corporation, Illumina,…

Monday, April 6th, 2020

According to a new report published by Proficient Market, titled, Global Biochip Market by Product Type (DNA Chips Market, Lab-On-A-Chip Market, Protein Chips Market & other) and by End-Users/Application (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes & Other) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 2027 The report has offered an all-inclusive analysis of the global biochip market taking into consideration all the crucial aspects like growth factors, constraints, market developments, top investment pockets, future prospects, and trends. At the start, the report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth.

According to the report, Global Biochip Market in 2019 stood at USD 14 billion and is expected to reach USD 62.82 billion by 2027 growing at a CAGR of 20.63% from 2020 to 2027.

Get Free Sample PDF (including full TOC, Tables and Figures) of Biochip Market @ https://proficientmarket.com/sample/1183

A biochip is a collection of microarrays organized on a solid substrate, allowing thousands of complex biochemical reactions, to determine various biological data, for instance, decoding the genes in less time. The biochip-based analysis is primarily used for on-site diagnosis. Biochips also undergo other diagnostic applications such as microarray technique, microfluidic technologies, & biosensors. A biochip can also provide analytical data regarding organic molecules associated with the living organisms. It helps in identifying airborne toxins, environmental pollutants, gene sequences, & other biochemical constituents.

Biochip Market Key Players: The research study includes profiles of leading companies operating in the global biochip market. Key players profiled in the report include:

Abbott Laboratories Agilent Technologies PerkinElmer Inc. Fluidigm Corporation Illumina GE Healthcare Bio-Rad Laboratories Inc. Cepheid Inc. Thermo Fisher Scientific F. Hoffmann-La Roche AG.

Do enquire to get a strategic overview of the market, Access Research Methodology Prepared By Experts at: https://proficientmarket.com/buying-request/1183

Thermo Fisher Scientific Inc. completed the acquisition of Affymetrix Inc., a leading provider of cellular and genetic analysis products. This acquisition helped Thermo Fisher to strengthen its leadership in biosciences, as well as acquire new genetic analysis capabilities to better serve clinical and applied markets.

Drivers for the Global Biochip Market: The increased use of biochips due to increasing cancer treatment and diagnostics. Rise in personalized medicine, drug discovery and life science research, need for high speed diagnostics and increased government funding are some of the key factors driving the growth for global biochips market. In addition, increasing healthcare awareness is also fueling the growth of global biochips market. Thus all these factors led to boosting the growth of the biochips market.

Opportunities for the Global Biochip Market: Rapid growing application of biochips will drive the market growth during forecasted period. While the Technological advancements and new product launches in the market are witnessed to augment the growth of the biochips market in forthcoming years. However, Rising demand of biochips in developing countries is witnessed to increase the market share of biochips. Moreover the Increasing adoption of personalized medicines by households will also propel the growth of the biochips market. Thus, all these factors will provide lucrative opportunities for the growth of the biochips market.

Restrains for the Global Biochip Market: The Strict government regulatory guidelines related to biochips are hampering the growth of the market. While the High instrument costs will also restrain the growth of this market. Lack of proper knowledge about biochip technology is a prominent restraint lowering the demand for biochip products. The irregularities arriving in healthcare coverage around the world are also more likely to challenge the growth of biochips market. Variable cost and adoption of biochip technologies is likely to affect the personalisation of medicine, eventually lowering the revenues of the global biochips market. Thus all these factors are creating a negative impact at the growth of the biochip market.

Region Wise, Global Biochip Market Analysis: Report covers the region wise analysis, global Biochip market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America leads the global Biochip market share followed by Europe and Asia Pacific. While the North America leads the global Biochip market due to the factors such as presence of well-established players, advanced informatics infrastructure, presence of experts and skilled workforce, and ongoing genomic R & D practices on a large scale in the region. While the rising R & D investments in genomic research is driving the growth of the market. Moreover, growing awareness regarding genetic tests for disease risk assessment and prevention is anticipated to have a positive impact on the growth of the regional market..

Access Full Report, here: https://proficientmarket.com/report/1183/global-biochip-market

Global Biochip Market: Product analysisDNA Chips MarketGene ExpressionSNP GenotypingCancer Diagnosis & TreatmentGenomicsDrug DiscoveryAgricultural BiotechnologyLab-On-A-Chip MarketClinical DiagnosticsGenomicsIVD & POCProteomicsDrug DiscoveryProtein Chips MarketProteomicsExpression ProfilingDiagnosticsHigh-Throughput ScreeningDrug DiscoveryOther Cell ArraysTissue Arrays

On the basis of type DNA Chips Market, accounted for largest share of total revenue generated due to the increasing use of DNA chip products. The use of DNA chip has empowered the scientific community by enabling measurement of the expression levels of large numbers of genes simultaneously. A DNA chip involves an array of microscopic spots each carrying numerous single-stranded oligonucleotides and are widely being used in biomedical research activities. Thus due to its huge utilization led to the growth of this segment which is fueling the biochip market.

Global Biochip Market: Application analysisBiotechnology and Pharmaceutical CompaniesHospitals and Diagnostics CentersAcademic & Research InstitutesOther

The demand of Global Biochip Market is highest from Biotechnology and Pharmaceutical Companies due to the numerous features offered by it. The utilization rate of biochips in biotechnology and pharmaceutical companies was high. The hospitals & diagnostics is the second fastest growing segment due to the adoption of biochip in new drug discovery as well as in point-of-care diagnostics has increased the consumption of these biochips in hospitals & diagnostics centers. Thus all these factors led to increase usage of biochips in this sectors which is propelling the growth of the biochip market.

Global Biochip Market: Region analysisNorth America: U.S., Canada, MexicoEurope: U.K., France, Germany, Spain, Italy, Rest of EuropeAsia Pacific: China, Japan, South Korea, ASEAN, IndiaRest of Asia Pacific: Latin America, Brazil, Argentina, Colombia, Rest of L.A.Middle East and Africa: Turkey, GCC, UAE, South Africa, Rest of Middle East

The report can be customized as per client requirements. For further queries, you can contact us on [emailprotected] or +1-773-800-2974. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Read the full press release and latest news of this report, here: https://proficientmarket.com/press-release/1188/global-biochip-market

About Us:Proficient Market is the leading research company offering both tactical and strategic support to all our customers. Customer satisfaction is our goal and that is why, we have a team of skilled and experienced specialists with the ability to do data mining, information management, and revenue enhancement solutions to ensure that our clients make informed decisions when coming to investing in the market. Our happiness is when we help our clients grow their business, strengthen the brands and educate their members or consumers through the ever-new fun research methods developed by our team.

Contact Us:Proficient Market1st Floor, Harikrishna Building,Samarth Nagar, New Sanghvi,Pune- 411027 IndiaTel: +91-8149441100 (GMT Office Hours)USA: +17738002974Email: [emailprotected]Web: proficientmarket.com

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at [emailprotected].

WiredRelease

Visit WiredRelease's Website

Here is the original post:
Insights On The Global Biochip Market To 2027 Featuring Abbott Laboratories, Agilent Technologies, PerkinElmer Inc., Fluidigm Corporation, Illumina,...

Read More...

The Growing Role of Artificial Intelligence in the Pharmaceutical Industry – BBN Times

Monday, April 6th, 2020

object(stdClass)#31465 (59) { ["id"]=> string(4) "5792" ["title"]=> string(69) "How Blockchain Improves Logistics: Benefits, Drawbacks, and Use Cases" ["alias"]=> string(66) "how-blockchain-improves-logistics-benefits-drawbacks-and-use-cases" ["introtext"]=> string(177) "

The blockchain technology and logistics industry tend to be quite profitable for each other. Additionally, this collaboration brings benefits to carriers and customers.

In this article, well discuss all you need to know about blockchain in the logistics sector.

Blockchain allows optimizing logistic processes in the real-time mode. This technology tends to improve the relationship between shippers and carriers.

We've singled out six main advantages of using blockchain in the logistics sector. Lets discuss them more precisely.

There are a lot of documents required for the transportation process. For example, a bill of lading or B/L. It stands for an agreement that consists of transportation terms, conditions, and other issues.

Blockchain allows recording all the steps. As a result, any participant can look through the delivery chain. If something happens, recorded information will report a problem.

Blockchain allows optimizing routes and delivering faster. In this case, smaller companies can compete with bigger ones, offering faster routes.

As a result, its possible to reduce expenses on the shipping process.

Blockchain simplified the process of goods certification. The combination of IoT and blockchain allows creating smart contracts.

Transactions made on blockchain are secure. Its impossible to change something in the transaction. It leads to decreasing fraudulent operations.

Intermediaries stand for agents that take part in the transportation chain. However, withlogistics software development, the industry doesnt need such specialists.

Weve already mentioned smart contracts. They tend to reduce time and expenses. Also, both parties have an opportunity to automate the validation process, manage obligations, and so on.

There were main blockchain advantages. As you can see, this technology can be quite profitable for the logistics industry.

Of course, there are some disadvantages of using blockchain technology. Lets discuss them more precisely.

Blockchain allows automating supply processes. As a result, there is no need for various specialists. The number of unemployed workers will rise.

Businesses that use blockchain technology should have a standard process. Unfortunately, these days, businesses dont have one.

Its required to create a standard process on the government level. So, businesses can follow it to avoid some common problems.

Its evident that blockchain development is expensive and time-consuming. Additionally, its required to have powerful hardware.

Also, there are expenses on specialists that are experienced in blockchain integration.

So, blockchain is a quite expensive technology that requires additional preparation before using it. However, some companies have already integrated blockchain and got some profit.

Blockchain makes it easy to track goods during shipment. Additionally, the companies have an opportunity to monitor the conditions of the packages.

As a result, its possible to detect broken goods, spoilt products, and so on.

Of course, such opportunities lead to decreasing unnecessary expenditures.

Successful story. Walmart cooperates with IBM to use the blockchain technology in the logistics. The system allows seeing what products are sold. Also, its possible to know the location of the product (the particular warehouse). The company claims that the supply process becomes more transparent.

Blockchain allows reducing the number of documents required for transportation. Additionally, the number of mistakes will also decrease due to automatization. The shipping terms fulfill more precisely.

Let's face it payments are important for any business. Blockchain makes this process secure. For example, its possible to make transactions with such cryptocurrencies as Bitcoin. As a result, the payment process is secure and transparent. Also, such solutions improve international processes.

Successful story. Tallysticks has made a platform that simplified payment processes using blockchain. The solution offers smart contracts that can be customized depending on the business needs and requirements.

Blockchain gives end consumers an opportunity to simplify the authenticity of the goods. There are platforms with data about product origin, quality, fineness, and others.

This technology gives clients transparency. As a result, people trust companies more.

Blockchain makes cooperation easier. For example, enterprises can cooperate with small companies to deliver goods faster. Such a solution is profitable for both parties.

These days, companies can cooperate with each other without intermediaries. It leads to cost reduction and improved delivery processes.

Successful story. ShipChain platform uses blockchain to improve cooperation. For instance, the service allows tracking the delivery from the warehouse to the buyer's door. It leads to better customer experience and satisfaction.

The delivery process is long and expensive. Also, there can occur various delays due to weather conditions and other issues.

Usually, to manage such issues, companies hire lawyers. However, blockchain changes the situation. The transportation process is tracked from the beginning to the end. So, both parties can see any changes in the route.

Also, the parties can monitor any issues connected to the delivery and decide whose fault they were.

Blockchain technology innovates the logistics sector. The companies can simplify the delivery process, making routes shorter.

All these solutions lead to customer satisfaction. As a result, the clients trust companies and order goods or services more often.

The main advantage of blockchain is transparency. Business owners, as well as end consumers, have an opportunity to track the delivery process. Also, customers can ensure that during the delivery the storing conditions were followed.

However, developing blockchain-based solutions is an expensive and time-consuming process. Companies have to prepare beforehand and single out the requirements of the final product.

Link:
The Growing Role of Artificial Intelligence in the Pharmaceutical Industry - BBN Times

Read More...

Precision Medicine Market to Witness a Healthy Growth during 2018-2025 – Curious Desk

Monday, April 6th, 2020

According to the latest study conducted by Trends Market Research (TMR) the global market for precision medicine is anticipate grow manifold, reflecting a robust CAGR of over XX% during 2018 to 2025.

Rapid augmentation of the medicine industry across the globe will certainly benefit the global market forprecision medicine. In addition, factors such as growing infrastructural development, higher investments, streamlined drug approval systems along with companion diagnostics are expected to favor the overall market growth during the assessment period. Cost-effective DNA profiling and increasing prevalence of carcinogenic diseases worldwide are additional factors that are projected to propel the market growth. Moreover, apt storage of genome data is of great significance to the global market for precision medicine as demand for data medicare is on the rise. However, acute data storage capacity, data privacy breach and discrepancies in funding systems and hefty price tag of personalized drugs may deter the market growth in the near future.

Enquiry More About This Report:https://www.trendsmarketresearch.com/report/sample/3437

The global market for precision medicine has been categorized into various parent segments that are further segmented into smaller sub-divisions.

On the basis of technology, next-gen sequencing, bioinformatics and drug discovery technology are expected to be the technologies highlighting the expanding the market width in forthcoming years. Based on applications, the oncology segment is expected to witness an overwhelming growth and is estimated to reach US$ XX Billion over 2025, reflecting a staggering XX% CAGR. This is primarily owing to increasing prevalence of tumor-related disease amongst the global geriatric population. On the other hand, increasing cases of arthritis will favor the growth of immunology segment, which is expected to surpass US$ XX Million in revenues by 2025 end.

Vendor News

Key players operating in the global market for precision medicine include Eli Lilly And Company, Novartis AG, AstraZeneca and Laboratory Corporation of America Holdings. Most of the companies are implementing market strategies involving mergers, tie-ups and acquisitions. Increasing collaboration between healthcare and IT is expected to deliver fruitful gains to the market, expanding the overall business canvas for the stakeholders in the upcoming years.

Request For Report Discounts @ https://www.trendsmarketresearch.com/report/discount/3437

The popularity of precision medicine has grown significantly across various parts of the world, hence on the basis of region, the markets for precision medicine in Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa (MEA) is set to achieve new figures of growth over the next eight years. Precisely, the market in North America is expected to present new lucrative opportunities, occupying over XX% share of the market during the forecast period. In addition, the region is estimated to surpass a market valuation of over US$ XX Million by the end of 2025.

The US and Canada will be the heavyweights of the global market owing to the existence of well-established medical industries in both the countries. In Europe, the market is expected to witness a steady growth and will increase its revenues charts close to US$ XX Million, riding on a healthy CAGR of over XX% during the assessment period. This is largely due to the increasing demand for precision medicines in countries such as France, UK, Italy and Germany. The Asia Pacific region is another region which is considered to be full of business potentials. The region is projected to increase at over XX% CAGR to reach approximately US$ XX Million by 2025 end. The market in APAC will be heavily dominated by Japan, while, India and China will compete for the second spot. Likewise, the in Latin America the market is expected to surge at a pace in terms of revenue over 2025. However, MEA will witness a sluggish growth of the market which is attributed to the lack of initiatives for conductive extensive research and development activities.

Make an Inquiry before [emailprotected] https://www.trendsmarketresearch.com/checkout/3437/Single

Visit link:
Precision Medicine Market to Witness a Healthy Growth during 2018-2025 - Curious Desk

Read More...

Page 33«..1020..32333435..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick